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Evolutionary biology considers which forms of life are possible and which of those forms 
is likely to appear and spread. Ecology tries to explain the dynamics and diversity of 
populations, typically assuming a fixed number of forms. On a fundamental level, they 
describe similar processes: two superficially polar examples are the neutral theories of 
evolution (Kimura 1983) and ecology (Hubbell 1997), which both account for the 
diversity of forms at the levels of genotypes and phenotypes, respectively. They differ in 
that the neutral theory of evolution assumes new forms arise by a constant rate of 
mutation, and the neutral theory of ecology assumes they appear by a constant rate of 
immigration. In these simple models, all extant forms are governed by identical and 
constant birth-death processes.  
 Ecological and evolutionary processes often occur at very different temporal 
scales, and it is not surprising that much progress has been made in each field by 
assuming the absence of noteworthy dynamics in the other. Limits to this separation of 
time scales can appear as rates of competition and phenotypic change converge. 
Ecological processes are, relatively speaking, fast: probably all life history strategies 
require intraspecific or interspecific interactions, which can occur repeatedly in a single 
generation. Convergence thus often arises as the units of selection increase their rates of 
mutation, whose effects can be complemented by recombination, horizontal gene 
transfer, and transformation. Another necessary component is a mapping between 
genotype and phenotype that allows rapid changes in genotype to be visible to selection. 
The robustness or genetic potential of genotype-phenotype maps can evolve adaptively in 
response to mutation rates and external pressures (Wagner 2007). The strength and speed 
of selection can be further augmented by large population sizes. Together, these factors 
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can permit a rapid evolutionary responsiveness to ecological change. Changes in 
phenotypes can then change the terms of the ecological interactions.  
Host-pathogen systems provide some of the most exciting cases of the 
convergence of evolutionary and ecological time scales. RNA viruses have the highest 
known mutation rates (Drake et al. 1998). Horizontal gene transfer and transformation 
allow bacteria to evolve literally within generations. Large population sizes are a 
distinction of small (e.g., unicellular or viral) organisms. What makes these systems 
particularly interesting relative to other microbial interactions are the multiple time scales 
of host evolution. On the shortest time scale—potentially on the order of several viral 
generations—is the phenotypically plastic response of hosts with adaptive immunity. 
Within hosts, immune cells and pathogens can undergo both consumer-resource 
dynamics and adaptive evolution (Mclean et al. 1991; Nowak et al. 1991; Perelson 2002). 
On a slightly longer time scale, pathogen evolution occurs against a backdrop of 
changing frequencies of susceptible, infected, and recovered hosts. Finally, hosts evolve 
improved immune defenses against pathogens over generations, and pathogens can 
further adapt to host populations. 
The best understood host-pathogen systems are unsurprisingly those where at 
least one time scale can be dropped. Major insights have been gained from ecological 
models that combine traditional disease dynamics with spatial structure (Keeling et al. 
2001), transmission networks (Lloyd-Smith et al. 2005), competition among multiple 
strains (Koelle et al. 2006; Nagao & Koelle 2008; Rohani et al. 2003), multiple hosts 
(Keeling et al. 2001; Schenzle 1984), and seasonal (Keeling & Grenfell 2002) and 
climatic forcing (Koelle et al. 2005; Pascual et al. 2006; Pascual et al. 2000). These 
approaches have worked for pathogens such as measles and cholera, which, despite their 
high intrinsic mutation rates, have relatively static phenotypes. Similarly, pathogen 
evolution is best understood when ecological feedback is restricted. Traditional tests of 
positive selection, for example, report long-term averages and ignore contributions of 
population dynamics (Suzuki 2006). The evolution of virulence has also classically been 
interpreted as independent from disease dynamics (Anderson & May 1982; Herre 1993) 
[but see Dwyer et al. (1990)]. 
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 For pathogens with high mutation rates, flexible genotype-phenotype maps, and 
rapidly changing ecologies, these models can be less useful. A recent wave of research 
attempts to integrate evolutionary and ecological theory and observations more finely 
under a framework labeled “phylodynamics” (Grenfell et al. 2004). Integrations include 
null models of strain evolution under SIR interactions (Gordo et al. 2009), strain 
evolution in transmission networks (Buckee et al. 2004), the stochastic dynamics of 
adaptation and invasion (Andre & Day 2005; Antia et al. 2003), the evolution of antiviral 
resistance during pandemics (Lipsitch et al. 2007), and inference of transmission rates 
and population size using coalescent theory (Biek et al. 2006; Pybus et al. 2001). No 
specific approach or set of assumptions dominates, beyond some integration of time 
scales; phylodynamic models clearly inherit their structure from traditional models in 
ecology or evolution and borrow as necessary from the other field. As the density of these 
models increases, a challenge will be to find ways to statistically validate them using both 
epidemiological and genetic observations (Cobey & Koelle 2008). 
 This dissertation is a series of investigations into the major ecological and 
evolutionary dynamics of one of the most enigmatic pathogens, influenza. Influenza 
undergoes rapid genetic and phenotypic evolution and infects multiple host species 
whose ecologies are in rapid flux. What follows is an overview of the virus’s natural 
history and a description of the hypotheses tested in this dissertation. 
 
Natural history of influenza 
 
Structure and antigenicity 
The genome of influenza consists of eight RNA segments, each 850 to 2300 bases, which 
code for ten proteins. Two of these proteins, hemagglutinin (HA) and neuraminidase 
(NA) are abundant on the virus’s surface, with approximately four HA for every NA. 
Within influenza A, there are sixteen general forms of HA and nine forms of NA. 
Combinations of HA and NA identify subtypes, e.g., H3N2. Amino acid sequences of 
HA differ up to 20% within subtypes and 30-70% between them (Skehel & Wiley 2000). 
Influenza B does not have subtypes. 
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 Hemagglutinin and neuraminidase are the primary determinants of antigenicity. 
Antibody-binding sites of some subtypes of HA and NA have been described by X-ray 
crystallography and electron micrographs of monoclonal antibody escape mutants 
(Bizebard et al. 1995; Fleury et al. 1999; Knossow et al. 2002). These sites are grouped 
into antibody-binding regions, or epitopes, on the globular head of hemagglutinin (HA1). 
In the 1980s, five epitopes (A-E) were identified on H3N2, but their relevance for 
contemporary strains in humans is unclear. HA1 of the H1N1 subtype has four or five 
recognized epitopes (Caton et al. 1982; Gerhard et al. 1981), and the N2 NA has at least 
two (Gulati et al. 2002). Different subtypes can share epitopes (Ekiert et al. 2009; Okuno 
et al. 1993; Smirnov et al. 1999; Yoshida et al. 2009). 
 Antibodies neutralize influenza viruses through steric inhibition of receptor 
binding or membrane fusion rather than inducing conformational change in HA. The 
receptor-binding site is a highly conserved pocket at the top of the HA1 (in H3N2, the 
site falls near epitopes A and B) and shows little variation among subtypes (Skehel & 
Wiley 2000). Antibodies can neutralize viruses by blocking the receptor-binding site 
directly (Bizebard et al. 1995) or by binding to an epitope some distance away (Fleury et 
al. 1999). Antibodies to the same epitope can compete or interact synergistically in 
neutralization (Brown et al. 1990; Sanna et al. 2000).  
 
Immunity 
Hosts resist infection through humoral immunity, cellular immunity, and innate 
immunity. The impact of each kind of immunity, especially to competitive dynamics 
among strains, is an open question.  
Healthy mammals infected with influenza develop several kinds of antibody 
responses. In the serum, initial infection provokes the production of antigen-specific 
immunoglobulin M (IgM), by clonal selection of mature B cells. After several weeks, 
IgM matures to IgG, which is more specific and forms the basis of long-lasting immunity  
(Yu et al. 2008). IgG can also confer maternal immunity via transplacental transfer (Puck 
et al. 1980; Reuman et al. 1987). Mucosal immunity and maternal antibodies secreted in 
breast milk are manifested by IgA (Renegar et al. 2004; Sweet et al. 1987).  
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Antibodies are probably the largest contributors to strain-specific immunity and 
cross-immunity within subtypes; they also may play a role in heterosubtypic immunity. 
Most antibodies in sera of infected or vaccinated humans target HA1 (Sato et al. 2004; 
Yu et al. 2008), though some individuals can also mount responses to NA (Cox & 
Brokstad 1999; Monto & Kendal 1973). All mammals investigated demonstrate 
antibodies to nucleoprotein (NP) (Cox & Brokstad 1999; Deboer et al. 1990). Antibody 
responses can be monoclonal (antibodies to one epitope are present in antisera) or 
polyclonal (antibodies to multiple epitopes are present); responses in natural host 
populations tend to be polyclonal, but they vary in depth and specificity.  
 Cellular immunity can significantly attenuate pathology and speed viral clearance, 
though it appears to play a lesser role in preventing infection [Liang et al. (1994) and 
review in Thomas et al. (2006)]. T-cells only attack presenting cells, and thus they 
usually lag behind IgM (in a primary response) or IgG (in a secondary response) in 
appearance and proliferation during infection. Mice challenged with a virus containing 
the internal proteins of human H1N1 produced CD8+ T-cells specific to all six internal 
proteins, though T-cells specific to epitopes on polymerase (PA) and NP predominated 
and could be detected ≥570 days after initial infection. Secondary responses tended to be 
dominated by NP (Belz et al. 2000; Marshall et al. 2001). CD4+ T-cells bolster CD8+ 
and B cell responses and appear requisite for T-cell memory (Belz et al. 2002). 
Studies on human immunity generally do not separate the effects of innate, 
cellular, and humoral immunity. They do, however, suggest there can be attenuation of 
symptoms during secondary infections, depending on strains’ antigenic relatedness 
(measured by hemagglutination inhibition, or HA relatedness) (Gill & Murphy 1977; 
Sonoguchi et al. 1985). It is possible that the strength of cross-immunity between strains 
changes with time since the first infection. One small study observed several cases of 
rapid reinfection with a heterologous subtype, sometimes within days of clearing the first 
subtype, and the secondary infection was no more likely to be asymptomatic than the first 
(Frank et al. 1983). In contrast, students at high schools experiencing concurrent 
epidemics of H3N2 and H1N1 were less likely to suffer multiple infections than students 
at schools with sequential epidemics (Sonoguchi et al. 1986).  
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Evolution 
Influenza viruses evolve by point mutations, reassortment of whole gene segments, and 
less frequently by recombination (Boni et al. 2008; Hirst et al. 2004; Suarez et al. 2004).  
Point mutations are influenza’s most frequent means of escaping immune 
surveillance, and they are also a means to modulate virulence, develop drug resistance, 
and adapt to new hosts or tissue types. Monoclonal antibody escape mutants can arise in 
vitro every 104 to 106 viruses (Webster & Laver 1980). They commonly avoid 
recognition through conformational changes, which tend to affect only the local structure 
within the surrounding epitope (Knossow et al. 1984). Hemagglutinin may be particularly 
tolerant of such changes. In H3N2, epitope A mostly consists of a loop extending from 
the rest of the molecule, and epitopes B and C are bulges (Wiley et al. 1981). While 
amino acids at certain positions, such as loops, might have a dramatically greater 
influence than others on antibody recognition, the location of influential positions can 
change over time (Nakajima et al. 2005). As for other pathogens, tertiary protein structure 
greatly complicates predictions of the locations of antibody epitopes (Korber et al. 2006). 
Influenza viruses can also potentially escape immune surveillance through the 
addition of glycosylation sites [Asn-X-Thr/Ser, where X is any amino acid except proline 
or potentially aspartic acid (Gallagher et al. 1992)]. In avian influenza viruses, the main 
role of glycosylation appears to be as a mediator of the relative binding affinities of HA 
and NA (Wagner et al. 2000). However, host cell carbohydrates could potentially bind to 
these sites also to form a “glycan shield” to antibodies. Glycosylation might be a major 
mechanism of antibody escape by HIV (Wei et al. 2003). The number of potential 
glycosylation sites on HA1 of H3N2 has increased from two to six or seven since the 
subtype emerged in humans (Abe et al. 2004). Glycosylation might thus be an especially 
rapid effecter of antigenic change in some influenza viruses in some hosts (Schulze 
1997), though it is not well tolerated by all subtypes of HA (Tsuchiya et al. 2002).  
The accumulation of point mutations in response to immune pressure has been 
labeled “antigenic drift” (Webster et al. 1992), and it underlies the characteristic 
phylogeny of H3N2 HA1 in human viruses: genetic distance steadily increases from the 
founding strain, and no strain persists more than a few years (Fitch et al. 1991). Recently 
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it has been shown that these strains in human H3N2 form antigenic clusters defined by 
cross-reactivity patterns. Only one cluster appears to dominate at any time (Smith et al. 
2004). Extended coexistence of lineages appears more common in H1N1 and influenza B 
(Chen & Holmes 2008; Nelson et al. 2008b). 
In contrast to antigenic drift, “antigenic shift” by reassortment—the reshuffling of 
HA and NA types—was once thought to be strictly associated with pandemics (Webster 
et al. 1992). There is growing evidence that reassortment might be as common in humans 
(Chen & Holmes 2008; Holmes et al. 2005; Lindstrom et al. 2004; Nelson et al. 2008a; 
Nelson et al. 2008b) as in other hosts (Hatchette et al. 2004; Webby et al. 2004), with the 
epidemic potential of the reassortant likely depending on the extent of preexisting 
immunity to its HA and NA (Monto & Kendal 1973). Reassortment might also lead to 
partial immune escape by changing other antigenic determinants, such as T-cell epitopes 
on internal genes. 
 
Ecology 
Influenza in humans is highly seasonal in temperate regions, with a three- to four-month 
epidemic period in winter and few cases in the summer (Cox & Subbarao 2000). 
Prevalence shows no clear periodicity in the tropics (Chow et al. 2006; Viboud et al. 
2006a). The mechanisms behind influenza’s seasonality are not understood (Lipsitch & 
Viboud 2009). Major hypotheses include increases in host susceptibility due to seasonal 
vitamin D deficiency (Cannell et al. 2006) and changes in viral transmissibility driven by 
humidity and temperature (Lowen et al. 2007; Schaffer et al. 1976; Shaman & Kohn 
2009). 
Pandemic and interpandemic influenza A (H3N2) strains circulate globally over 
short time periods, while H1N1 and influenza B viruses show more spatial structure and 
less rapid mixing (Finkelman et al. 2007). H3N2 outbreaks have high spatial synchrony 
(Bonabeau et al. 1998; Greene et al. 2006; Viboud et al. 2006b), and phylogenetic studies 
of strains circulating in France (Lavenu et al. 2006), Japan (Nakajima et al. 1991), New 
York (Nelson et al. 2006), and the continental United States (Nelson et al. 2008a) 
demonstrate that multiple lineages seed annual epidemics in each community. Swabs 
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from air travelers support the hypothesis that there is interhemispheric transport of strains 
throughout the year (Sato et al. 2000). A recent model proposes that a network of 
populations in East and Southeast Asia supports year-round transmission of H3N2, with 
antigenically novel variants arising from this network and spreading throughout the world 
(Russell et al. 2008).  
In humans, incidence is usually inferred from deaths to pneumonia and influenza. 
Until recently, few countries tracked deaths or infections by type and subtype. 
Observations from WHO collaborating labs reporting to the CDC suggest that seasons 
dominated by H3N2 have relatively low incidence of H1N1 and/or influenza B and vice-
versa (Finkelman et al. 2007; Greene et al. 2006; Thompson et al. 2003). Estimates of 
annual incidence range from 5-20% in interpandemic years and 40-50% during 
pandemics (Cox & Subbarao 2000). Contact with young children is a significant risk 
factor for infection (Gubareva et al. 2002; Viboud et al. 2004), and vaccination of young 
children can dramatically reduce incidence in older contact children and adults (Hurwitz 
et al. 2000; Monto et al. 1970). 
 Many other species can be infected with influenza viruses. Multiple subtypes of 
influenza A are endemic in swine, domestic poultry, and horses. Influenza A is seasonal 
in many aquatic birds, which are its natural hosts (Halvorson et al. 1983). Repeated 
transmission between wild birds and domestic poultry (Alexander 2000; Munster et al. 
2005; Zhou et al. 1999), birds and swine (Ludwig et al. 1994; Webby et al. 2004), 
domestic poultry and humans (Bridges et al. 2002; Lin et al. 2000; Olofsson et al. 2005), 
and swine and humans (Claas et al. 1994; Gregory et al. 2001; Myers et al. 2006; Olsen et 
al. 2000; Ottis et al. 1982; Peiris et al. 2001) occurs in many parts of the developed and 
developing world where the populations cohabitate. Influenza B has only been found in 
humans and seals (Webster et al. 1992). 
 
Overview of dissertation 
The dynamics of influenza are poorly understood because of limited surveillance, 
uncertainty about the nature and strength of hosts’ immune responses, the pathogen’s 
rapid evolution, and the breadth of factors that appear relevant to its ecology. This 
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dissertation presents explanations of how the diversity of influenza viruses is regulated by 
a combination of ecological and evolutionary mechanisms. Chapters 2 and 3 examine the 
dynamics of influenza viruses in humans: Chapter 2 explores molecular evidence for a 
theory of H3N2 evolution in humans, and chapter 3 attempts to resolve the fundamental 
epidemiological differences between H3N2, H1N1, and influenza B. Chapter 4 presents a 
theoretical model, motivated by recent observations of influenza and other pathogens, of 
how strains might compete when their phenotypes are perceived differently by different 
hosts. Chapter 5 investigates how host ecology could shape the long term evolution of 
influenza viruses’ host range. 
 
Chapter 2. Episodic positive selection in H3N2 
Several hypotheses have been proposed to explain why, given influenza’s high mutation 
rate and strong selection pressures from immune surveillance, the genetic diversity of 
influenza strains remains bounded. One of the more contentious hypotheses proposes that 
H3N2 undergoes “epochal evolution”: most mutations are phenotypically neutral, but 
some occasionally have large effects on phenotype. Any novel phenotype has a selective 
advantage, since it partially escapes immune surveillance. It might also competitively 
exclude the resident phenotype. With certain assumptions about the nature of the 
genotype-phenotype map of HA, this process can generate cyclical patterns of genetic 
diversity over time that coincide with the replacement dynamics of major antigenic 
phenotypes. In chapter 3, I present independent evidence for episodically strong and 
otherwise weak, continuous positive selection in the HA of H3N2. I also test the 
hypothesis that the punctuated changes in antigenicity are driven by the addition of 
potential glycosylation sites near HA epitopes rather than epistatic point mutations. 
Finally, I consider the relative strength of selection in influenza’s other genes and suggest 
where deviations from epochal evolution might have occurred. 
 
Chapter 3. Cross-immunity and the dynamics of influenza A and B in humans 
Influenza A (H3N2 and H1N1) and B all show interannual variability in their attack rates 
and positive selection in their HA. An intriguing question is whether the dynamics of 
 10 
H1N1 and B might also be driven by epochal evolution or whether there might instead or 
in addition be competition between types or subtypes. Competition at these levels is 
suggested by historical patterns of subtype replacement, phase displacement between 
H3N2 and (as a set) B and H1N1, and heterosubtypic cross-immunity demonstrated in 
challenge experiments in nonhuman hosts.  
In this chapter, I describe novel observations from St. Petersburg, Russia, of 
influenza’s hospitalizations by subtype over several decades. I propose that major 
patterns can be explained by differences in the epidemiological and evolutionary rates of 
each type and subtype. Using a recently developed method of nonlinear dynamical 
inference, I also statistically evaluate the potential for heterotypic and heterosubtypic 
immunity over this time period.  
 
Chapter 4. Strain competition under a multidegenerate genotype-phenotype map 
An implicit assumption in models of strain competition is a one-to-one or many-to-one 
mapping between genotype and phenotype. Empirical evidence shows that such an 
assumption is not always biologically accurate. The phenotypes of pathogens that are 
mainly targeted by cellular immunity, for example, will be defined by recognition by host 
MHC alleles; two strains might thus be competitors in some hosts but not others. There is 
also evidence that hosts often mount heterogeneous antibody responses to pathogens such 
as influenza and HIV. In the same vein, strains that differ in a few but not all of their 
epitopes may thus be perceived as identical in some hosts but not others.  
Rather than a one-to-one or many-to-one genotype-to-phenotype mapping, 
heterogeneity in host immunity implies that a single genotype can be perceived as several 
different phenotypes by hosts with identical infection histories. This chapter shows how 
including a multidegenerate genotype-phenotype map affects a traditional model of strain 
competition, and specifically how the diversity of strains can be influenced not only by 
the strength of cross-immunity but also by the diversity of host responses. Parameterizing 
such models will be increasingly tractable in the future as data accumulate on the genetic 
composition of host populations, immunodominance of various epitopes, and breadth of 
immune repertoires.  
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Chapter 5. Evolution of influenza’s host range 
Recent research tends to focus on specific mutations that might be required for avian 
viruses, such as H5N1, to adapt to humans. This chapter takes a broader perspective, 
asking instead how host range should evolve given a basic set of ecological and 
evolutionary assumptions. Molecular work reveals that influenza viruses face tradeoffs in 
their ability to infect different host species. This chapter focuses on one such tradeoff, the 
virus’s preference for one of two possible forms of hosts’ sialic acid receptor. Influenza’s 
reservoir, waterfowl, has one form of this receptor, humans have another, and two 
potential “intermediate hosts”—chickens and pigs—have both forms of the receptor. This 
analysis uses the approach of adaptive dynamics to investigate how different ecologies 
influence the evolution of viruses’ preference for one or the other form of the sialic acid 
receptor.  
For a broad range of ecologies, specialists to each receptor type can easily coexist. 
Interestingly, ecological differences have a greater effect than tradeoff strength on the 
evolution of host range. Analysis of a neutral ecological case suggests these results are 
extensible to other pathogens facing similar tradeoffs. 
 
Together, these chapters test hypotheses of how influenza’s diversity might be regulated 
over different time scales and host populations. The first and last chapters focus on 
evolutionary dynamics and the middle two on ecological processes; the third and fourth 
are generalizable across host species, while the first and second focus specifically on 
evolution in humans. In addition, every chapter presents different methods for integrating 
ecological and evolutionary hypotheses. The results here should contribute to our 
understanding of not only influenza but also other host-pathogen systems whose 
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The high burden of influenza in humans is a direct consequence of the virus’s ability to 
escape preexisting immunity. Long-term immunity to influenza is mediated by 
antibodies, which confer lifelong protection to specific strains and partial cross-immunity 
to others (Gill & Murphy 1985; Yu et al. 2008). Most antibodies target influenza’s 
surface proteins, especially its hemagglutinin (HA). The process by which influenza 
viruses escape recognition by prevailing antibodies through point mutations has been 
called “antigenic drift” (Webster et al. 1992).  
 Considering influenza’s high mutation rate and the strong positive selection on 
HA, it is surprising that the genetic diversity of influenza viruses remains bounded rather 
than proliferating over time (Ferguson et al. 2003). Two kinds of hypotheses have been 
proposed to account for the restricted diversity. The first argues that pathogen diversity is 
restricted by a density-dependent process that causes an additional reduction in the 
number of susceptible hosts beyond the intrinsic dynamics of a seasonally-forced SIR 
model (Ferguson et al. 2003; Tria et al. 2005). This reduction has been ascribed to 
“generalized immunity,” a hypothetical phenomenon that would protect a recently 
recovered individual from infection with any influenza strain for an approximately six-
month period. Models that invoke generalized immunity have also incorporated other 
factors, such as heterogeneity in host transmission and variation in strain fitness, to 
explain dynamics. Notably, the concept of generalized immunity was motivated by 
computational simulations rather than laboratory experiment; empirical support for 
generalized immunity is modest. Enhanced cellular immunity following influenza 
infection in mice can confer partial protection to subsequent infections (Thomas et al. 
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2006), but there is still no evidence of broad, transient protection in humans. In fact, 
humans can be reinfected and infectious within days of clearing infections with another 
subtype (Frank et al. 1983).  
 Another hypothesis to explain the restricted diversity of HA over time is that 
individual mutations in HA, rather than always having small effects on antigenicity, can 
occasionally cause large changes in antigenic phenotype. If these changes are sufficiently 
abrupt, they can displace resident strains through cross-immunity. Selective sweeps have 
been proposed previously for H3N2 HA (Fitch et al. 1991) and H1N1 HA (Ina & 
Gojobori 1994), though the dynamics of the antigenic diversity of HA of any subtype has 
been characterized only recently (Smith et al. 2004). Remarkably, strains of H3N2 from 
1968 to 2003 fall into eleven distinct antigenic clusters, inferred from cross-reactivities of 
antisera from ferrets challenged with these strains. Each cluster dominates within one or 
two years of its emergence and persists for roughly one to eight years before being 
displaced by a novel cluster. A longitudinal study of reinfection in humans suggests that 
cross-immunity may be as high as 95% within clusters and 60-84% between clusters (Gill 
& Murphy 1977).  
These observations were synthesized in a model of “epochal evolution” for H3N2 
(Koelle et al. 2006). In contrast to the assumptions of previous models, which postulate 
that genetic distance correlates linearly with antigenic distance (and therefore cross-
immunity), the clusters support the assumption that the continuous genetic change 
observed in H3N2 HA can cause punctuated antigenic change. Most nucleotide and 
amino acid substitutions do not result in cluster transitions and therefore have negligible 
effect on antigenicity or fitness. The model proposes that the nonlinear mapping between 
genotype and phenotype can be approximated by evolution on connected neutral 
networks. A founding strain begins in a neutral network, i.e., a set of genotypes that are 
connected by single mutations and map to the same phenotype, and diffuses through 
high-dimensional genotype space via mutations until arriving at a node (sequence) 
belonging to an adjacent network. This new phenotype, which presumably has 
structurally significant amino acid substitutions in whichever epitopes are being targeted 
by the host population, has a larger supply of susceptibles than do strains in the old 
network. The model posits that the new network corresponds to one of two kinds of 
 23 
phenotypic change: a mutation may either cause a slight change in antigenicity, 
corresponding to evolution within a cluster, or a major change, corresponding to the 
discovery of a new cluster. In the former case, cross-immunity between strains on 
adjacent networks remains high, and in the latter case, cross-immunity is lower. When a 
novel cluster arises, it can rapidly outcompete the resident cluster through cross-
immunity, though clusters can also coexist.  
The authors support their argument by showing in simulations that a neutral 
network model can reproduce both the characteristic phylogeny of HA and also the 
spikes in incidence that are associated with cluster transitions. Further, the authors 
predict, and confirm with sequence data and simulations, boom-and-bust cycles of strain 
diversity: diffusion in genotype space causes the average pairwise genetic distances of 
extant strains to increase as a cluster spreads. This diffusion in genotype space can be 
seen in the phylogenies of some clusters. For example, in clusters BE89 and BE92, 
multiple lineages persist from one year to the next. The trees of WU95 and SY97, in 
contrast, generally have unidirectional growth, which echoes the traditional descriptions 
of HA trees as a whole. This pattern could be due to sampling or genetic drift, perhaps 
augmented by off-season extinction, but it also suggests selective sweeps might occur 
within clusters. Similarly, the patterns in BE89 and BE92 could reflect neutral evolution 
or positive selection. 
Selection within clusters might be a nontrivial component of influenza’s 
evolutionary and ecological dynamics. It could suggest that influenza’s fitness is 
modulated by more than escape from antibodies to HA, that ferrets are a poor model for 
human immunity, or that neutral networks are a poor representation for evolution within 
HA. There is additional indirect evidence that selection on HA occurs within clusters. 
Koelle et al. (2006) found that realistic cycles and increases in genetic diversity were not 
obtainable without the option of minor phenotypic changes within clusters. The 
incomplete cross-immunity demonstrated in longitudinal studies and frequent 
observations of antigenic drift in HA from season to season suggest this result is 
biologically plausible (Gill & Murphy 1977; Russell et al. 2008). However, it is also 
possible that within-cluster evolution is modulated by selection on T-cell epitopes on 
other genes, antibody epitopes on NA, or factors unrelated to immunity.  
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This chapter tests whether there is support for the idea that episodic positive 
selection in H3 HA is associated with the major antigenic clusters. I also examine 
evidence for weaker selection within clusters in HA. Finally, I weigh evidence for 
selection driven by other parts of the genome. I find weak within-cluster positive 
selection, driven by mutations at antibody-binding epitopes in HA and the addition of 
glycosylation sites. Positive selection also appears over long time scales in NA, NP, M2, 
and potentially several other proteins. The results suggest that immune escape, primarily 
from antibodies to HA, is the driving selective pressure on influenza. Other forms of 
immunity and other components of fitness probably contribute less to the dynamics. The 
results confirm that a model of strictly neutral evolution within clusters is inappropriate; 
positive selection operates continuously, though with varying intensity. 
 
Positive selection on hemagglutinin 
Multiple aspects of HA could be under selection, including the stability of secondary 
structures involved in transcription, usage bias of its codons, and the final structure of its 
protein. Changes in secondary structure are positively selected in avian H5N1 (Gultyaev 
et al. 2007), though no research appears to have been done on this topic in human 
influenza. Codon usage bias is a characteristic of many viruses. It is usually associated 
with adaptation to new host environments: At least in theory, viruses that adopt the codon 
bias of host cells have access to optimal tRNA frequencies, speeding translation (Ikemura 
1981; Zuckerkandl & Pauling 1965). The increases in replication efficiency resulting 
from codon bias can have profound effects on viral fitness even when the amino acid 
structure is unchanged (Coleman et al. 2008). However, there is only a weak correlation 
between the genome-wide codon biases of influenza A and B viruses and their human 
and chicken hosts (Scapoli et al. 2007) and the bias appears to be under strong 
phylogenetic conservation (Zhou et al. 2005). Nonetheless, significant, positive 
correlations between these viruses and the genes expressed in host epithelial or 
gastrointestinal cells (in humans and birds, respectively) might exist and have yet to be 
investigated. Codon bias can also arise from mutational pressure. Codons in the epitopes 
of HA in human H3N2 show a bias toward substitutional changes relative to NA and NP, 
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potentially reflecting recent frequency dependent selection (Plotkin & Dushoff 2003). A 
whole-genome study of multiple influenza A subtypes found that codon bias appears 
mainly driven by GC composition, a marker of mutational bias (Zhou et al. 2005). 
Selection on synonymous codons is thus a potential factor in the long-term evolution of 
human influenza viruses, but it is an unlikely cause of strongly episodic selection.  
The first part of this analysis tests for positive selection on the protein structure of 
HA. Traditional tests of positive selection on protein structure compare the relative 
frequencies of nonsynonymous (replacement) substitutions per nonsynonymous site to 
synonymous (silent) nucleotide substitutions per synonymous site. An excess of 
nonsynonymous substitutions is the hallmark of positive selection. In nucleotide 
substitution models, the nonsynonymous substitution rate is given by dN (in codon 
substitution models, β) and the synonymous rate by dS (α), with their ratio represented as 
dN/dS (β/α = ω); for convenience, I use them interchangeably in the text. Tests based on 
dN and dS have the advantage of not making specific assumptions about population 
dynamics during the period in which selection might have occurred (Kosakovsky Pond & 
Frost 2005b).  
The relationship between dN and dS is the subject of the following investigations, 
which test for positive selection on the HA of putative cluster founders, within clusters, 
and in influenza’s other genes. The investigations use a powerful approach for detecting 
selection in taxa with potentially weakly positive selection and relatively low divergence: 
Rather than fitting substitution rates on a site-by-site basis, they assume a distribution of 
discrete rate classes across sites (supplementary material). This approach, dubbed 
Random Effects Likelihood (REL), is thus able to detect significant weak selection across 
many sites where site-by-site inference (Fixed Effects Likelihood, FEL) would fail to 
find significant deviation from neutrality for each individual site. This approach is not 
without its weaknesses, however. Where possible, I complement results with those from 
the far more conservative site-by-site method. In both approaches, likelihood 
comparisons of fitted, unconstrained models to those in which dN is constrained to equal 
dS reveal whether positive selection is operating. 
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Selection on cluster founders 
The antigenic clusters identified by Smith et al. (2004) are also clustered 
monophyletically, reflecting the common descent of strains assigned to a particular 
cluster. If selection on cluster founders were strong and positive, the dN/dS ratio of trunk 
branches connecting disparate phenotypes should be elevated compared to other 
branches, which represent evolution within clusters. In principle, of the within-cluster 
branches, the candidates most likely to be positively selected are those along the trunk: 
mutations on the trunk are specifically the ones most apt to be conserved in future 
lineages, and thus might have initially been positively selected.  
 Unfortunately, the low divergence of the HA phylogeny precludes meaningful 
calculations of dN and dS on individual branches. Instead, I test for a necessary, but not 
sufficient, pattern supporting the model of Koelle et al. (2006): significantly elevated 
dN/dS in some sites in the set of branches linking clusters (i.e., in putative cluster 
founders, as a group) and no elevation of dN/dS on the set of the other trunk branches. 
Episodic positive selection on HA would predict dN/dS > 1 in the first group. If evolution 
within clusters is neutral, dN/dS should be statistically indistinguishable from one in the 
second group. If there is still positive selection within clusters, the dN/dS of the second 
group should exceed one in some sites. We would expect it to be lower than that of the 
first group if the model of Koelle et al. (2006) is correct, i.e., if there is strong positive 
selection on cluster founders. 
 Comparisons of dN/dS among branch sets were made using the modified branch-
site test of positive selection (Yang 1997; Yang & Nielsen 2002; Zhang et al. 2005). This 
method compares fitted dN/dS substitution rate categories in two sets of branches, the 
“foreground” and “background,” which are determined a priori. One class of sites [class 0 
in Yang & Nielsen (2002) and Zhang et al. (2005)] includes codons under negative 
selection and is fitted so that 0 < ω0 < 1. Class 1 includes codons under neutral evolution 
and is set equal to one. Class 2a codons are under positive selection in the foreground (at 
rate ω2) and purifying selection (ω0) in the background; class 2b codons are under 
positive selection (ω2) in the foreground and neutral evolution (ω1) in the background. To 
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detect positive selection, the model in which ω2 is fitted is compared by the likelihood 
ratio test to a model in which ω2 is constrained to be one in the foreground branches.  
In the first analysis, the foreground branches correspond to the cluster-substitution 
branches along the trunk, and the background branches are all other trunk branches. To 
construct the phylogeny, the TVM + Γ codon substitution model was chosen for the 253 
antigenically typed HA sequences used in Smith et al. (2004). Available models were 
compared via AIC using MrAIC software (Nylander 2004). This codon substitution 
model was then used to infer the phylogeny by maximum likelihood in PHYML 
(Guindon & Gascuel 2003). The branch-site test of positive selection was executed in 
PAML version 3.15 using the codonml (a derivative of codeml) routine (Yang 1997). 
 When no site-by-site variation is allowed, the dN/dS ratio for the entire HA on the 
branches linking clusters is 0.38, reflecting the predominance of purifying selection to 
which HA as a whole is subjected. When categories ω0, ω1, and ω2 are fitted, the cluster-
transition branches show a class of sites with strong and significant positive selection (ω2 
~ 8.6) compared to the neutral model (2ΔL = 15.6, p < 0.01; χ2, d.f. = 1) (table 2.1). The 
six sites found under significant positive selection by Bayes empirical Bayes analysis 
(Yang et al. 2005) are all located within known antibody epitopes (table 2.2). 
 When the same models are fitted to the trunk branches corresponding to within-
cluster evolution, reversing the foreground and background branches, the unconstrained 
model shows a ω that is elevated (approximately 2.2) but not significantly different from 
one (2ΔL = 1.36, p < 0.24; χ2, d.f. = 1) (table 2.1). Two of the three positively selected 
sites are in known epitopes (table 2.2).  
 The branch-site test of positive selection thus gives results consistent with 
episodic selection on the tertiary structure of HA, driven by antibody escape at known 
epitopes, and demarcated by the major phenotypes reported by Smith et al. (2004). It 
cannot, however, provide resolution at the level of individual cluster transitions, and thus 
it cannot exclude the hypothesis that some cluster transitions were not associated with 
positive selection on HA. It further assumes that sites remain in the same class, i.e., that 
selection pressures on them do not change over time. It also cannot exclude significant 
positive selection within clusters, not only because of the necessary aggregation of 
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branches and sites in this test but also because only branches along the trunk are 
considered. Positive diversifying selection, suggested in some of the phylogenies of 
individual clusters, could cause elevated dN/dS ratios along twig and tip branches. Low 
divergence again prohibits resolution of dN/dS for individual branches, and thus the next 
test of selection also relies on inference of rate classes. 
 
Selection within clusters 
A REL approach was used to test for positive selection within clusters (Kosakovsky Pond 
& Frost 2005a). REL as implemented in HyPhy (hereafter “REL”) is a more general case 
of the branch-site test of positive selection and is similarly suited to detecting weak 
positive selection across an alignment (Kosakovsky Pond et al. 2005). The approach uses 
the codon substitution model of Muse and Gaut (1994). Parameters are then fitted, given 
a phylogeny (supplementary material). As in the branch-site test of positive selection, 
REL assumes a discrete distribution of rate classes, and the number of such classes is 
declared a priori. A major difference between the two models is that REL assumes both 
synonymous and nonsynonymous rates can vary, while the branch-site test assumes only 
variation in nonsynonymous rates. 
 REL was applied separately to the six most sampled clusters identified by Smith 
et al. (2004) (average number of samples per cluster = 28, range = 16-51), since results 
below these sample sizes are less reliable (Kosakovsky Pond & Frost 2005b). For each 
cluster, trees were built in the PHYML online server (Guindon & Gascuel 2003; Guindon 
et al. 2005) using the HKY substitution model (Hasegawa et al. 1985), a four-category 
gamma distribution of rate classes and an additional class of invariant sites. The REL 
models were then fitted, again assuming the HKY substitution model, in HyPhy. Models 
of increasing complexity were sequentially tested: the number of synonymous and 
nonsynonymous rate classes was incremented until there was no improvement in AIC. 
The maximum likelihoods of the unconstrained models were then compared to those of 
models in which the highest nonsynonymous substitution rate was constrained to equal 
the synonymous substitution rate (i.e., where no positive selection was allowed, and all 
other rate classes were fitted). 
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 For each of the six clusters examined, a model that fit multiple dN and dS rate 
classes independently performed better than models with a single mean dN/dS (table 2.3). 
In every cluster, models that allowed positive selection outperformed models in which 
the highest rate class was constrained to one. The differences in performance were more 
dramatic in some clusters than others (e.g., BE92 v. BE89).  
Every cluster had at least one site under positive selection; virtually all of these 
sites were located in known antibody epitopes, with the only two exceptions immediately 
adjacent to sites in epitopes (table 2.4). Only one of the sites under positive selection on 
the trunk in the branch-site test of positive selection was identified as positively selected 
in these clusters in the REL analysis (site 156, in epitope B, positively selected in SI87). 
This difference might arise from model misspecification by the branch-site test (e.g., in 
disallowing synonymous rate variation) or, more likely, long-term changes in selective 
pressures over the trunk that are not found in the short-term selective regimes of the 
clusters—a sign of epistasis (Koelle et al. 2006) or changes in the foci of antibody 
pressure. Two sites (226 in epitope D and 278 in epitope C) were under positive selection 
in more than one cluster. Direct estimation of rates at individual sites with FEL 
(supplementary material) failed to identify most of these sites as positively selected (table 
2.S1). This is not surprising, considering the low divergence and small sample sizes of 
the clusters. However, each of the three sites found positively selected by FEL was also 
found selected by REL. 
 
Glycosylation 
During viral assembly, oligosaccharides present in the host cell can attach to the surface 
of viral proteins. N-linked sites that are potentially glycosylated (PNGS) during 
replication in vivo have the sequence Asn-X-Thr/Ser, where X is any amino acid except 
proline or potentially aspartic acid (Gallagher et al. 1992). Glycosylation is thought to 
play a major role in the function not only of influenza but also of HIV, Hendra, SARS-
CoV, hepatitis C, and West Nile viruses (Vigerust et al. 2007). In HIV, the addition of 
PNGS has been associated with antibody escape (Wei et al. 2003; Zhou et al. 2007), 
though it does not necessarily correlate with the strength of neutralizing antibody 
 30 
responses (Frost et al. 2005). There is similar diversity in the potential roles of 
glycosylation in HA of influenza. The addition of a glycosylation site in influenza B was 
associated with a decrease in the effectiveness of ferret antisera  (Nakagawa et al. 2004). 
Experimental addition of a PNGS to HA was able to block antibody binding in the 
laboratory (Skehel et al. 1984); experimentally added sites have also been shown to 
disrupt transport activities, inhibit receptor binding, shield multiple epitopes 
simultaneously, and interfere with each other (Gallagher et al. 1992). There is evidence 
that glycosylation is an important factor in influenza’s host-specific receptor binding 
abilities (Gambaryan et al. 1998). In avian influenza viruses, increases in the receptor 
binding strength of HA require compensation in the cleaving abilities of NA (Baigent & 
McCauley 2001; Wagner et al. 2000).  
In human influenza viruses, however, most attention has been given to the 
hypothesis that PNGS in H3N2 HA are positively selected for immune escape. The 
number of PNGS in the HA of H3N2 has increased from six in 1968 to eleven in 2004. 
Abe et al. (2004) argue that several of the new PNGS appeared for the first time in major 
antigenic variants, and that glycosylation may thus play an important role in antigenic 
drift. Support for this position also comes from comparisons of H3 HA in different hosts 
and different HA types (Zhang et al. 2004). Avian H3 HA, which is probably under less 
positive selection, shows no increase in the number of PNGS over time. Human H1 HA, 
which is also probably under less intense selection, shows a slower, non-monotonic 
increase in sites with time. 
 Since PNGS are formed over short time scales by single amino acid substitutions, 
they are a clear case in which the dN/dS ratio can fail to detect major changes in 
structural phenotype that are positively selected. Notably, Smith et al. (2004) and Koelle 
et al. (2006) could not find any sites where substitutions were consistently predictive of 
transitions to new clusters; this pattern might appear if PNGS were precipitating major 
antigenic changes. To determine whether PNGS were associated with cluster transitions, 
PNGS were mapped to the phylogeny of HA (figure 2.2; table 2.5). The majority of 
PNGS appear on the trunk of the tree, suggesting they are positively selected upon 
appearance and then conserved. PNGS losses tend to occur on terminal branches. 
Remarkably, no PNGS additions or losses are associated with cluster transitions. It is thus 
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unlikely that they are associated with the major antigenic changes in HA. However, their 
placement suggests they improve the fitness of HA, perhaps by improving receptor 
binding or intracellular trafficking. Because of their potential interaction with NA, they 
also suggest that it might be important to consider the extent of possible influence of 
other genes on HA. 
 
Positive selection on other genes 
To determine whether other genes might be under positive selection and could precipitate 
partial or complete selective sweeps independently of antibody pressure on HA, REL 
analysis was performed on the rest of the influenza genome. To construct the most evenly 
sampled phylogeny, GenBank sequences were drawn primarily from Asia and chosen to 
span 1968 to the late 1990s (see supplementary material for accession numbers). Trees 
were built in the PHYML online server (Guindon & Gascuel 2003; Guindon et al. 2005) 
using the general time reversible substitution model, a four-category gamma distribution 
of rate classes and an additional class of invariant sites. The REL models were then fitted, 
again assuming a general reversible substitution model, with HyPhy software. 
 The best-fitting models for all genes except PB2 are those allowing positive 
selection in some sites (table 2.6). Considering both the size of the difference in AIC—
that is, the ΔAIC between the constrained and unconstrained models—and the results of 
the empirical Bayes (table 2.7) and FEL analyses (table 2.S2), there is strong support for 
positive selection in HA, NA, NP, and M2, followed by a weaker signal in PA, PB1, M1, 
and NS1 and NS2. However, the FEL model, which is known to have an extremely small 
rate of false positives and high rate of false negatives for small data sets (Kosakovsky 
Pond & Frost 2005b), sometimes found stronger support (i.e., lower p values) for 
selection at particular sites relative to the REL models’ Bayes factors. Rate “smoothing” 
is a known problem of REL models and can cause underestimation of positive selection 
when small numbers of sites are selected [Kosakovsky Pond & Frost (2005b) and 
Kosakovsky Pond, pers. comm.). Thus, this analysis might not be effective at ruling out 
strong positive selection on a few sites in any gene. With its temporal aggregation, it also 
fails if selective regimes change on individual sites over short periods of time.  
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Discussion 
This study presents evidence consistent with episodic positive selection on the antigenic 
phenotypes defined by Smith et al. (2004). It also suggests that evolution within these 
phenotypes is not strictly neutral, in support of the model of Koelle et al. (2006). 
Potential sources of positive selection on HA within clusters include antibody-mediated 
selection in known epitopes and selection for PNGS. Since models of influenza’s 
ecological and evolutionary dynamics tend to assume that strain-level selection can be 
approximated by selection on HA, other genes were examined for the presence of 
positively selected sites. Results suggest that positive selection is indeed strongest in HA, 
but it also likely shapes the evolution of NA, NP, and M2, and other proteins to a lesser 
extent.  
 Several competing perspectives have arisen on the precise tempo of positive 
selection in HA. Wolf et al. (2006) published analyses of H3N2 HA sequences collected 
over 1995 to 2005. Rather than inferring rates of dN and dS, they looked for and found a 
strong positive correlation between the number of nonsynonymous relative to 
synonymous substitutions in a lineage and the speed with which contemporary lineages 
went extinct. They found that the nonsynonymous substitutions tended to occur in HA’s 
known B-cell epitopes, and that intervals between periods of rapid lineage turnover were 
characterized by a lower ratio of nonsynonymous to synonymous substitutions. They did 
not attempt to correlate periods of presumed antigenic turnover to the clusters identified 
by Smith et al. (2004), but their periods with high turnover appear to correspond to 
cluster emergence events (of WU95, SY97, and FU02); only one additional period of 
rapid lineage replacement (in SY97) was found. Notably, they did not otherwise find an 
excess of nonsynonymous substitutions during intervals of apparent stasis. Their findings 
are thus in keeping with the model of episodic positive selection, though they suggest 
mostly neutral evolution occurs between episodes of rapid displacement. 
 Two other studies use molecular evidence to argue instead for a model of 
continuous, positive, and effectively non-episodic selection on HA. Shih et al. (2007) 
plotted the frequency of amino acid fixation events in HA over time, using all H3N2 
sequences available in GenBank. They found that most fixation events tended to occur 
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very rapidly and in most years, and that the majority of replacements were associated 
with known antigenic sites. Their analysis contains two flaws. First, the presence of 
several rapidly fixed sites within clusters is not inconsistent with a model of episodic 
positive selection; the model of Koelle et al. (2006) produces multiple fixation events in 
within clusters, despite the fact that cross-immunity within strains of the same cluster is 
high but imperfect (i.e., that positive selection is relatively weak)(figure 2.S1). Second, 
clusters do not emerge synchronously everywhere in the world, and inferring fixation 
rates from sequences aggregated over multiple locations and seasons (e.g., the latter half 
of the 2004-2005 season in the Northern hemisphere, the 2005 season in the Southern 
hemisphere, and the beginning of the 2005-2006 season in the northern hemisphere) 
creates an extended, artificial overlap between clusters that spreads the timing of fixation 
events; in any one location, fixation events are probably quite abrupt (K. Koelle, pers. 
comm.). Performing the same exercise with the data of Smith et al. (2004) gives the 
impression of much more continuous positive selection (K. Koelle, unpublished results). 
 A study by Suzuki (2008), which uses an approach similar to the first analysis 
presented here, also claims continuous, non-episodic positive selection. Suzuki 
partitioned branches into four groups, depending on whether they occurred on or off the 
trunk and whether they corresponded to within-cluster evolution or cluster transitions. He 
then used  maximum parsimony analysis to infer whether positive selection occurred in 
branches in each category, focusing only on epitope sites (designated a priori). He found 
significant positive selection on the trunk branches, even when the cluster transitions 
were excluded, and neutral evolution in the epitopes off the trunk. It is not surprising that 
he did not find positive selection off the trunk, since his approach aggregates 
substitutions across sites within epitopes and could potentially mask the effects of 
positive selection at a few sites. His finding positive selection on the non-transition trunk 
branches conflicts with the analysis here, which found that sites in non-transition trunk 
branches were not significantly positively selected. The difference might be due to a 
failure in the fitting algorithm or differences in the underlying evolutionary models. It is 
curious that Wolf et al. (2006) also used codeml in PAML to infer dN/dS in the epitopes 
of all trunk branches from a 100-taxa subset of their sequences from 1995-2005 and 
failed to find significant positive selection. To resolve these ambiguities, it would be 
 34 
helpful to fit models that allow for variation in synonymous as well as nonsynonymous 
substitution rates. This investigation would also be strengthened by the availability of 
more antigenically typed taxa. Despite large sequencing and antigenic typing efforts [e.g., 
Russell et al. (2008)], only the several hundred sequences published in Smith et al. (2004) 
are associated with publicly available antigenic information. 
This analysis presents several new findings on selection in non-HA genes of 
influenza. In a genome-wide study of all H3N2 sequences in GenBank, Suzuki (2006) 
found significantly positively selected sites only in HA (two sites, positions 220 and 
229), NA (one site, position 370), and NP (one site, position 131), despite the fact that at 
least 6% of the codons in every gene had dN/dS > 1 (but not significantly). His analysis 
relied on an extremely conservative site-by-site ancestral reconstruction of dN and dS 
using maximum parsimony. Bragstad et al. (2008) also reported no positively selected 
sites in the internal genes of H3N2 sequences collected in Denmark from 1999 to 2006 
using a similarly conservative method. This study, in contrast, uses a more realistic model 
of sequence evolution and presents stronger evidence for long-term selection in genes 
outside HA. It also indicates (through ΔAIC of REL models and site-by-site methods) the 
relative strength and targets of selection. After HA, these results suggest NA might be 
under strongest selection pressure. One of its three positively selected sites occurred in a 
known B-cell epitope, and positively-selected site 120 is adjacent to site 119, which is 
associated with oseltamivir resistance (Abed et al. 2006). NP and M2 also appear 
positively selected. Several of their positively selected sites are in known T-cell epitopes, 
as are two sites in M2 [as identified in Suzuki et al. (2006)]. The major role of NP is 
genome encapsidation in preparation for RNA transcription; NP also interacts with RNA, 
viral RNA polymerase, and in close conjunction with M1 protein as well as host cell 
actin, nuclear RNA helicase, and other components (Portela & Digard 2002). Information 
on the roles of specific NP residues is scant. Suzuki (2006) reports that the position of 
131 in NP is unknown; position 290 can serve as an antibody epitope in vitro (Varich & 
Kaverin 2004). Interestingly, many of the positively selected sites (NP positions 77, 98, 
and 136) in this study have continued to evolve more recently (Ghedin et al. 2005). M2 
also fills functional and immunogenic roles. M2 forms the ion channel, which is the 
target of adamantane drugs; our data do not encompass the recent rise of adamantane 
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resistance, which is conferred by the S31N mutation (Nelson et al. 2009). The exposure 
of the protein to the surface of the virus allows it to be targeted by antibodies. All of 30 
young adults tested in one study showed relatively high antibody titers to M proteins, and 
some showed faster and stronger antibody responses to M upon vaccination or challenge 
than to HA or NA (Khan et al. 1982). Recent clinical trials of a vaccine based on the M2 
ectodomain have also demonstrated immunogenic epitopes (Schotsaert et al. 2009). A 
more comprehensive, recent analysis (Furuse et al. 2009) also finds positively selected 
sites in M2, including site 16 (located in the ectodomain) but not 81 (in the cytoplasmic 
domain). Since M1 and M2 share a 71-nucleotide reading frame, changes in M2 (e.g., at 
site 3) might necessitate compensatory mutations in M1. Immune-mediated selection on 
HA or M1 (through M2) might similarly drive compensatory changes in NP. It is also 
feasible that compensatory changes in genes might arise from functional changes in other 
genes with which they closely interact. 
 The patterns in glycosylation found in this study [also corroborated and published, 
after this analysis was performed, by Blackburne et al. (2008)] suggest that selection 
might occur via reassortment on whole genes or gene combinations. This hypothesis was 
not tested here, though some authors have argued (largely based on few examples, and 
for which counterexamples are available) that reassortment between HA and NA has 
preceded the emergence of major antigenic variants or especially successful strains (Chen 
& Holmes 2008; Nelson et al. 2008; Rambaut et al. 2008; Wolf et al. 2006). Hypothesis-
driven exploration of specific interactions between genes, and between specific sites and 
functions (immunologic and non-immunologic), will help resolve the contribution of 
different genes to influenza’s dynamics. This study suggests which genes outside HA 
most warrant investigation. Better resolution of antigenic and genetic data on HA and 
other genes in the next few years should allow a more quantitative understanding of 


















Figure 2.1. Phylogeny of H3N2 HA showing antigenic clusters (colored tips) and 






















Figure 2.2. Phylogeny of H3N2 HA showing antigenic clusters (colored tips) and 
locations on branches where potential N-linked glycosylation sites (PNGS) were added 
















Table 2.1. Results of the modified branch-site test of positive selection. Site classes are 
described in the main text. The proportion of sites assigned to each class is listed in the 




0 1 2a 2b
Unconstrained model -7870
Proportion 0.74 0.24 0.02 0.01
0.10 1.00 0.10 1.00
0.10 1.00 8.58 8.58
Neutral model -7885
Proportion 0.69 0.22 0.07 0.02
0.10 1.00 0.10 1.00
0.10 1.00 1.00 1.00
Unconstrained model -7880
Proportion 0.75 0.25 0.00 0.00
0.10 1.00 0.10 1.00
0.10 1.00 2.24 2.24
Neutral model -7879
Proportion 0.72 0.24 0.03 0.01
0.10 1.00 0.10 1.00































Table 2.2. Sites positively selected along the HA trunk. according to posterior 

































































Table 2.3. Constrained and unconstrained REL models for the six best-sampled clusters. 
Column n gives the number of taxa available for the cluster. The non-positive discrete 
models are those that constrain β ≤ α, while the unconstrained models do not. The dual 
models allow rate variation in both β and α, as described in the text. Numbers under each 
model are AIC scores; the best-performing models are in bold. The ΔAIC column gives 
the difference between the AIC of the best-performing non-positive discrete and best-







Cluster n Constant Dual Constant Dual
BK79 16 4179.0 4136.4 4140.0 4134.5 1.9
SI87 20 4110.1 4071.1 4069.0 4068.9 2.1
BE89 37 4129.7 4100.8 4103.8 4100.0 0.8
BE92 51 5568.3 5492.4 5535.0 5461.2 31.3
WU95 28 4613.7 4574.8 4592.6 4561.9 12.9
SY97 16 3912.9 3909.9 3907.9 3905.3 4.7
Non-positive discrete Unconstrained Δ 
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Table 2.4. Sites positively selected by REL in the HA of the six best-sampled clusters. 
Sites adjacent but not directly in an epitope have the epitope listed in parenthesis. The last 
column lists the log of the Bayes Factor (BF) that β > α at that site. Sites positively 
selected with a BF between 20 and 50 are in italics; sites positively selected with BF >50 




Cluster Site Epitope log(BF)
BK79 137 A 3.07
213 D 8.14
SI87 156 B 6.87
186 B 6.94























WU95 226 D 7.99
SY97 144 A 6.58
199 (B) 6.87
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Table 2.5. Potential N-linked glycosylation sites (PNGS) in HA. B-cell epitopes are 
listed if any part of the PNGS overlaps them. The third column gives the cluster in which 






Sites Epitope Cluster Notes
8-10 - Present except for small clade in HK68
22-24 - Present throughout
38-40 - Present throughout
45-47 C SI87, BE89 Appears only in clades in SI87 and BE89
63-65 E EN72 Present in HK68, lost, regained in EN72 and 
then fixed
81-83 E HK68 Lost when PNGS at sites 63-65 added




165-167 B/D - Present except for small cllade in WU95 and 
VI75
246-248 D BK79
276-278 C BE92 Added and lost within BE92
285-287 - Present throughout
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Table 2.6. Constrained and unconstrained REL models for all genes. Column n shows the 
number of taxa included for each gene. The non-positive discrete model constrains β ≤ α, 
while the unconstrained model does not. Numbers under each model are AIC scores; the 
best-performing models are in bold. The ΔAIC column gives the difference between the 
AIC of the best-performing non-positive discrete and best-performing unconstrained 
model. The last column indicates whether positively selected sites (PSS) were identified 
by empirical Bayes in REL with Bayes Factor >20 (“R”, table 2.7) or with p < 0.05 by 









Δ Protein n Non-positive Unconstrained  AIC PSS
HA 213 16720.24 16659.74 60.5 R, F
NA 196 15781.63 15728.47 53.16 R, F
NP 95 12186.42 12176.59 9.83 R, F
PA 78 15255.04 15254.21 0.83 R
PB2 75 16550.39 16550.63 0.24
PB1 78 14403.06 14402.82 0.24 -
M1 183 7221.37 7220.38 0.99 R
M2 183 3272.28 3255.6 16.68 R,F
NS1 80 5359.29 5358.57 0.72 -
NS2 80 2388.77 2388.69 0.08 -
 46 
Table 2.7. Sites positively selected by REL in all genes. The epitope column lists B-cell 
epitopes by their letter names and any known T-cell epitope (TCE), followed by the 
epitope’s associated HLA allele [from Suzuki (2006)]. Sites adjacent but not directly in a 
B-cell epitope have the epitope listed in parenthesis. The last column lists the log of the 
Bayes Factor (BF) that β > α at that site. Sites positively selected with a BF between 20 
and 50 are in italics; sites positively selected with BF >50 are in normal type. Epitopes 







Protein Site Epitope log(BF)
HA 133 A 3.26
135 A; TCE (HLA-A*1101) 3.78


























375 TCE (HLA-DQA1*0501; HLA-DQB1*0201) 4.54
421 TCE (HLA-B*0702; HLA-B*3501) 3.71
450 4.38
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Table 2.7 (continued) 
 
 














PB2 - - -
PB1 - - -
M1 3 3.98
219 3.92
235 TCE (HLA-DQw3) 3.56
M2 3 3.71
11 TCE (HLA-B*44) 4.28
13 TCE (HLA-B*44) 3.31






81 TCE (HLA-CW*0102) 3.94
85 TCE (HLA-CW*0102) 3.24
NS1 - - -





Description of REL and FEL models 
The following description is a short summary of definitive presentations that can be 
found in Kosakovsky Pond & Frost (2005b) and Kosakovsky Pond et al. (in press). 
 Both models assume sites evolve according to an unobserved codon substitution 
rate matrix. The rate of substituting non-stop codon x with non-stop codon y (x ≠ y) at site 
s under the MG94 and general reversible model is given by: 
MG94 × REVx,y (dt) =  
0, 
! 
"sRij# j p dt , 
! 
"sRij# j p dt , 
x → y requires ≥2 nucleotide substitutions, 
x → y is a synonymous substitution of 
nucleotide i with nucleotide j, 
x → y is a nonsynonymous substitution of 




Rij is the substitution rate of nucleotide i for nucleotide j, and 
! 
" j p is the frequency of the 
target nucleotide j in codon position p ∈ {1, 2, 3}. The reversible model posits that Rij = 
Rji. Traditionally, RAG is set equal to one, and the other rates are fitted. To save time, rates 
Rij in codon models can be approximated by those from nucleotide substitution models, 
which account for target nucleotide frequencies 
! 
" j  but (by definition) not codon 
positions p.  
The model assumes that each site s has a specific rate of synonymous and 
nonsynonymous substitutions, αs and βs. FEL attempts to infer directly the individual 
rates, αs and βs, for each site. REL assumes a distribution of discrete rates d ∈ {1,…, D} 
in D categories, where D is fixed a priori. These rates, αd and βd, are found by 
maximizing the likelihood of the entire alignment, which is given by the product of 








$ . (3.S2) 
 
In the branch-site test of positive selection, αs = 1 and βs = ωs. In the 
unconstrained model, rate categories ωd are fitted for foreground and background 
branches separately. In FEL and REL, both α and β can be allowed to vary. In the REL 
analysis here, rates were drawn from general discrete distributions and allowed to vary 
independently.  
Fitting a model by REL or FEL in HyPhy traditionally begins with inferring 
nucleotide substitution rates Rij, base frequencies 
! 
" j , and branch lengths from a given 
tree (which was itself constructed from a substitution model of some kind). A hybrid 
codon-nucleotide substitution model is then derived by assuming unchanged rates Rij and 
proportional branch lengths; the latter will be used to scale αs and βs. Alternatively, a full 
codon model can be fit from a given tree.  
Next, αs and βs (or αd and βd) are fit, assuming that each branch is an independent 
realization of the substitution process, though weighted by uncertainty in ancestral states. 
Positive selection in each model is revealed by demonstrating that the unconstrained 
model in which β > α outperforms the nested null hypothesis (α = β) by the likelihood 
ratio test. Both the branch-site test of positive selection in PAML (Yang et al. 2005) and 
REL (Kosakovsky Pond & Frost 2005b) as implemented in HyPhy further attempt to 
classify sites by empirical Bayes analysis. 
In the analysis here, full codon models with four discrete rate classes were used 
for most of the gene-level REL analyses (exceptions were PB1 and M, which did not 
appear able to converge on a codon model, and for which three discrete rate classes were 
fit). Full codon models were used in all the cluster analysis, and the number of rate 
classes was incremented until AIC ceased to improve; all clusters have two synonymous 
and two or three nonsynonymous classes. 
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GenBank accession numbers 
 
HA: AY660991-AY661211, AF008665, AF008697, AF008711, , AF008725, AF008755, 
AF008769, AF008828, AF008867, AF008886, AF008888, AF008903, AF008905, 
AF092062, AF131997, AF180570, AF180602, AF180643, AF201874, AF368444, 
AF368446, D21173, D49961, ISDN38157, ISDNCDA001, ISDNENG72, ISDNHK71, 
ISDNTX77, ISDNVIC75, M16739, U08858, Z46405, Z46408, Z46413, Z46414 
 
NA: AY210126, AY210129, AY210131, CY006685, U42631, CY007973, CY003554, 
CY006309, AY210134, AY210135, CY003530, AB124660, CY009006, CY006909, 
CY003498, CY006046, CY003730, AB124661, AB124663, CY006765, DQ508827, 
K01150, CY006101, CY006205, CY003490, CY006054, CY006757, CY006853, 
CY003738, CY003722, CY006317, CY006325, CY003746, CY008174, CY003522, 
CY003538, CY003506, CY003546, U42633, CY003514, DQ508835, U42635, U42636, 
U42770, U42771, U42772, U42773, CY003714, CY033608, U43427, CY036905, 
CY009014, CY006349, AF038260, U42777, U42778, U42779, U42780, U43419, 
U43422, U43426, CY006341, CY003754, CY007837, U71140, U71141, U71142, 
U71143, U51246, AF038261, AJ457945, AF038262, AF038263, AF038265, AF038264, 
EU857285, EU857289, EU857293, EU857295, EU857296, EU857298, EU857120, 
EU857126, EU857127, EU857130, EU857131, EU857169, EU857174, EU857175, 
EU857176, EU857172, EU857180, EU857181, EU857182, EU857183, EU857201, 
EU857202, EU857208, EU857212, EU857282, EU857283, EU857284, EU857286, 
EU857287, EF584349, EF584358, EF584359, AJ457939, EU857100, EU857101, 
EU857104, EU857105, EU857107, EU857108, EU857109, EU857110, EU857111, 
EU857112, EU857152, EU857153, EU857154, EU857155, EU857156, EU857157, 
EU857158, EU857159, EU857160, EU857161, EU857162, EU857163, EU857164, 
EU857165, EU857166, EU857167, EU857168, EU857303, EU857306, EF584371, 
AF382329, AF382330, AF382331, AF382332, AF386761, AF386763, AF386764, 
AJ293923, AJ457931, AJ457936, AJ457938, EU857096, EU857097, EU857098, 
EU857099, EU857113, EU857114, EU857115, EU857116, EU857117, EU857121, 
EU857128, EU857129, EU857132, EU857147, EU857148, EU857149, EU857246, 
EU857251, EU857252, EU857253, EU857254, EU857264, EU857266, EU857268, 
AJ457933, AJ457934, EU857170, EU857171, EU857173, EU857177, EU857178, 
EU857179, EU857185, EU857189, EU857203, EU857204, EU857205, EU857206, 
EU857207, EU857233, EU857234, EU857235, EU857236, EU857237, EU857238, 
EU857239, EU857240, EU857242, EU857243, EU857244, EU857317, DQ249253, 
EU857133, EU857134, EU857136, EU857144, EU857146, EU857188, EU857191, 
EU857193, EU857195, EU857196, EU857198, EU857199, EU857211, EU857213, 
EU857226, EU857229, EU857231, EU857260, EU857261, EU857262, EU857269, 
EU857312, EU857313, EU857314, U42776, DQ415341, DQ415342, DQ415343, 
AY589662, AY589663, AY589664, AY589666, AY589669, AY589670, AY589672, 
AY589673, AY589674, AY589676, AB281206, EU857321, EU857327, EU857345, 
AB433818, AB433819, EU857137, EU857138, EU857139, EU857192, EU857194, 
EU857197, EU857200, EU857214, EU857215, EU857216, EU857217, EU857218, 
EU857219, EU857220, EU857221, AB281193, AB281196, AB281198, EU857255, 
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EU857256, EU857257, EU857258, AB281201, AB281203, EU857270, EU857271, 
EU857300, EU857301, EU857331, EU857333 
 
NP: AY210227, AY210230, AY210231, AY210232, CY006686, CY007974, 
CY009359, CY009639, D00051, AY210234, AY210236, AY210238, CY003555, 
CY006310, L07344, CY003531, CY009007, CY006910, CY003499, CY006047, 
CY003731, L07358, L07359, CY006766, DQ508826, CY006102, CY006206, 
CY003491, L07361, CY006055, CY006758, CY006854, CY006318, CY003739, 
CY003723, M22577, CY003747, CY006326, CY008175, CY003523, CY003507, 
CY003539, DQ508850, L07366, L07367, CY003547, CY003515, CY035201, 
DQ508834, L07372, L07373, L07374, L07353, L07354, L07357, CY035209, 
CY035217, CY036834, CY035225, CY035233, CY033609, CY003715, AF038254, 
CY009015, CY036906, CY006350, U71144, CY007838, CY003755, CY006342, 
AY936880, AF038255, AB019358, AB019361, U71145, U71146, U71147, CY038506, 
AF038256, AF038257, AF038258, AF038259, AF255748, AF255749, AF483604, 
AJ458277, CY036850, AB019359, AB019360, AJ293924, AJ458276, DQ487330, 
EU097851, EU097845, EU097846 
 
PA: AY210199, AY210202, AY210203, CY006688, CY007976, CY009361, 
CY009641, DQ508928, AY210205, AY210206, AX350188, CY003557, CY006312, 
CY003533, CY009009, CY006912, CY003501, CY003733, CY006049, CY006768, 
DQ508824, CY006104, CY006208, CY003493, CY006057, CY006760, CY003725, 
CY006856, CY006320, CY003741, CY003749, CY006328, CY008177, CY003541, 
CY003509, CY003525, DQ508848, CY003549, CY003517, CY035203, DQ508832, 
CY035211, CY035219, CY035227, CY035235, CY033611, CY003717, AF037424, 
CY006352, CY036908, U71136, CY006344, AF037425, U71137, U71138, U71139, 
CY038508, AF037426, AF037427, AF037428, AF037429, AF257197, AF257198, 
AF483603, CY036852, AJ293922, DQ487327, EU097809, EU097820, EU097821, 
DQ415308, DQ415309, DQ415310, EU097815, EU097816, EU097818, EU097819, 
CY037348 
 
PB2: AY210144, AY210146, AY210148, CY006690, AX350184, AY210149, 
AY210150, CY003559, CY006314, CY007978, CY009363, CY009643, DQ508926, 
M91712, CY003535, CY009011, CY003503, CY006914, CY003735, CY006051, 
CY006770, DQ508822, CY003495, CY006106, CY006210, CY006059, CY006762, 
CY003727, CY003743, CY006322, CY006858, CY003751, CY006330, CY008179, 
CY003511, CY003527, CY003543, DQ508846, CY003551, CY003519, CY035205, 
DQ508830, CY035213, CY035221, CY036838, CY035229, CY035237, CY003719, 
CY033613, AF037412, CY006354, CY036910, CY006346, U71132, AF037413, 
U71133, U71134, U71135, CY038510, AF037414, AF037415, AF037416, AF037417, 
AF258841, AF258842, AF483602, CY036854, AJ293920, DQ486029, DQ415286, 
DQ415287, DQ415288, AB443559, AB443560, CY037350 
 
PB1: AF037418, AF037419, AF037420, AF037421, AF037422, AF037423, AF258822, 
AF258823, AF483601, AX350186, AY210279, AY210281, AY210282, AY210283, 
AY210284, CY003494, CY003502, CY003510, CY003518, CY003526, CY003534, 
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CY003542, CY003550, CY003558, CY003718, CY003726, CY003734, CY003742, 
CY003750, CY006050, CY006058, CY006105, CY006209, CY006313, CY006321, 
CY006329, CY006337, CY006345, CY006689, CY006761, CY006769, CY006857, 
CY006913, CY007977, CY008178, CY009010, CY009362, CY009642, CY033612, 
CY035204, CY035212, CY035220, CY035228, CY035236, CY036837, CY036853, 
CY036909, CY037349, CY038509, DQ415297, DQ415298, DQ415299, DQ487328, 
DQ508823, DQ508831, DQ508847, DQ508927, EU097778, EU097779, EU097780, 
EU097781, EU097782, EU097783, EU097800, U71128, U71129, U71130, U71131  
 
M: AY210260, AY210263, AY210265, CY006684, CY006308, AY210267, AY210270, 
CY003553, CY007972, CY009005, CY003529, CY003497, CY006908, CY006045, 
CY003729, CY006764, K01140, DQ508828, CY006100, CY006204, CY003489, 
CY006053, CY006756, CY003721, CY006852, CY006316, CY003737, CY003745, 
CY006324, CY008173, CY003537, CY003505, CY003521, CY003545, CY003513, 
AF401293, L18999, DQ508836, CY033607, CY003713, CY006348, CY036904, 
CY009013, U65561, U65562, U65563, U65564, U65566, U65567, CY006332, 
CY006340, CY003753, AJ458339, U65573, U65574, U65576, U65577, U65568, 
U65569, U65565, AF038271, AF038272, AF038273, AF255369, EU597867, EU597868, 
EU597871, EU597873, EU597874, EU597876, EU597878, EU597879, EU597885, 
EU597887, EU597888, EU597890, EU597891, EU597897, EU597898, EU597899, 
EU597901, EU597904, EU597908, EU597909, EU597910, EU597912, EU597913, 
EU597914, EU597915, EU597919, EU597920, EU597921, EU597922, EU597924, 
EU597925, EU597926, AJ458305, AJ293925, AF386765, AF386767, AF386770, 
AF386771, EU597927, EU597928, EU597929, EU597932, EU597935, EU597938, 
EU597939, EU597940, EU597944, EU597945, EU597946, EU597947, EU597950, 
EU597951, EU597952, EU597953, EU597954, EU597955, EU597957, EU597958, 
EU597959, EU597964, EU597967, EU597969, EU597970, EU597971, EU597972, 
EU597973, EU597974, EU597978, EU597980, EU597986, EU597987, EU597988, 
EU597989, EU597990, EU597991, EU597992, EU597993, EU597995, EU597996, 
EU597998, EU597999, EU598002, EU598009, EU598010, EU598012, EU598013, 
EU598014, DQ249266, DQ415352, DQ415353, EU598016, EU598017, EU598018, 
EU598019, EU598021, EU598023, EU598024, EU598025, EU598031, EU598032, 
EU598033, EU598034, EU598035, EU598036, EU598038, EU598039, EU598040, 
EU598041, EU598042, EU598044, EU598045, AB281207, AB433834, AB433835, 
AB281194, AB281197, AB281199, AB281204, DQ849010 
  
NS: AY210306, AY210307, AY210310, AY210311, CY006687, AY210312, 
AY210314, AY210315, CY003556, CY006311, CY007975, CY009360, CY009640, 
DQ508933, V01102, CY003532, CY009008, CY003500, CY006911, CY003732, 
CY006048, CY006767, DQ508829, CY003492, CY006207, CY006056, CY006759, 
CY003724, CY003740, CY006319, CY006855, CY003748, CY006327, CY008176, 
CY003508, CY003524, CY003540, DQ508853, CY003516, CY035202, DQ508837, 
CY035210, CY035218, CY035226, CY035234, CY036835, CY003716, CY033610, 
CY006351, CY009016, CY036907, CY003756, CY006335, CY006343, CY007839, 
U65670, AF038275, CY038507, U65671, U65672, U65673, U65674, AF038276, 
AF038277, AF038278, AF038279, AF256182, AF256183, CY036851, AJ293941, 
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AM502801, DQ487332, AB434123, AB434124, AM502797, CY037347, DQ415363, 
DQ415364, DQ415365, EF675055 
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Cluster Site Epitope p-value
BK79 - - -
SI87 186 B 0.09
BE89 - - -
BE92 138 A 0.09
226 D <0.01
WU95 - - -
SY97 - - -
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Figure 2.S1. Amino acid fixation events in a simulated and a real cluster. Top image 
shows simulated sequence evolution, and bottom shows replacements in the BE92 
cluster. Colors indicate different amino acids; rows are sites. White areas show where no 
single amino acid is fixed at that site. The cluster was simulated from the model of Koelle 
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Cross-immunity and the dynamics  




The threat of influenza to human health arises not only from the virus’s complex 
ecological and evolutionary dynamics but also the relative obscurity with which it moves 
through human populations. Over long time scales, the diversity of influenza viruses is 
shaped by transmission with other host species (Webster et al. 1992), and over short time 
scales by patterns of global circulation (Rambaut et al. 2008; Russell et al. 2008). In both 
situations, competition between strains for susceptible hosts regulates influenza diversity. 
The primary driver of its evolution appears to be escape from host antibodies, but the 
tempo of this escape, the ultimate constraints on antigenic shapes available, and the 
contributions of different genes to fitness are not clear. The biggest obstacle to testing 
hypotheses about influenza remains the fact that the vast majority of its population 
dynamics are recorded indirectly. One result is that the epidemiological community still 
has little ability to predict the consequences of introducing H5N1 or an antigenically 
novel strain of H1N1 into the human population, much less what type or subtype may 
predominate in the next season. 
 We present here novel analysis of the most accurate and lengthy observations to 
date of influenza’s three major phenotypes—influenza B and influenza A, which includes 
subtypes H3N2 and H1N1—collected over two decades from the population of present-
day St. Petersburg, Russia (figure 3.1a). We use these observations to fit simple 
epidemiological models to each of the three strains, yielding information about the 
strains’ different reproductive rates and the rates of antigenic evolution. An important 
question is whether variation in strain prevalence from year to year arises from strain-
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specific dynamics alone or whether subtypes or types are also in competition with each 
other. Interference between H3N2 and B has been suggested previously from 
observations of alternating dominance between seasons (Ferguson et al. 2003). 
Heterosubtypic cross-immunity within influenza A is suggested by historical patterns of 
subtype replacement in humans (Earn et al. 2002; Epstein 2006; Ferguson et al. 2003; 
Monto & Kendal 1973) and laboratory and challenge experiments in animals (Benton et 
al. 2001; Boon et al. 2004; Heinen et al. 2001; Kurimura et al. 1973; Liang et al. 1994; 
Smirnov et al. 1999; Van Reeth et al. 2004). Our results suggest cross-immunity between 
H3N2 and influenza B and possibly other pairs. There might be some potential for 
predictability in influenza’s dynamics from season to season at the level of types or 




We analyzed monthly counts of serologically confirmed cases of influenza A H3N2 and 
H1N1 and influenza B among patients hospitalized for advanced respiratory disease in St. 
Petersburg, Russia (then Leningrad, USSR). Data were aggregated from adult and 
children’s hospitals by the Research Institute of Influenza in St. Petersburg and have been 
described previously (Karpova et al. 2006). The hospitals’ policy throughout this period 
was to attempt to obtain paired serological samples from all patients. The first sample 
was obtained upon admission and the second upon discharge. A confirmed case of a 
strain was defined as a fourfold or greater increase in antibody titer to that strain. Though 
data exist through 2004, we restrict our observations to avoid unknown but potentially 
dramatic changes in host behavior and sampling methods that may have accompanied the 
fall of the Soviet Union in December 1991. We analyze only the subset spanning January 
1969 to June of 1991, though data are missing for 1971. Our model is ultimately fit to 




Our fitted model has two components: a process model and a measurement model. The 
process model is a mechanistic representation of the underlying disease dynamics. The 
measurement model describes how observations are generated from the dynamics. After 
describing both components in detail below, we outline the procedure used to fit the full 
model.    
 
Process model 
The disease dynamics are represented by a set of coupled stochastic differential 
equations. We track the number of hosts susceptible (S), infected (I), and recovered (R) to 
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The number of individuals susceptible to strain i increases with births and loss of 
immunity and decreases with deaths and infections; the infections may be with strain i or 
other strains j that share some cross-immunity with i. Monthly per capita birth and death 
rates, B(t) and D(t), were inferred from splines fitted to annual data for the city of St. 
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Petersburg (Karpova 2004)(figure 3.1b). The rate of loss of immunity, γi, is strain-
specific and constant in time.  
The rate at which individuals susceptible to i acquire infection with i depends on 
strain-specific, seasonally varying transmission rate, βi(t) (equation 4.1e), to which we 
add a strain-specific gamma noise term, ξi(t) = ξi /Δt, to capture stochastic changes in 
antigenicity, 
ξi ~ Γ(shape = Δt/φi , scale = φi). (4.3) 
 
Since confirmed influenza cases in St. Petersburg consistently peak in winter, we force 
βi(t) with a sinusoidal function whose maxima are fixed on January 1 and whose 
amplitude, ε, is shared by all strains. Finally, we allow a small, constant rate of 
immigration m that ensures frequent reseeding of locally extinct strains. We set this rate 
to be approximately 8.3 y-1, meaning a susceptible, on average, contacts an infected 
person from outside St. Petersburg once every eight years. 
Individuals susceptible to i can also leave the susceptible class from infection with 
related strain j. The infection rate with strain j is analogous to infection with strain i, 
except that rather than becoming infectious with strain j (which does happen, but is 
tracked by dSj/dt and dIj/dt) individuals can become immune to i. The status-based 
approach assumes that cross-immunity is polarizing (Gog & Swinton 2002): Rather than 
all individuals infected with strain j developing a slight reduction in susceptibility to i, 
some fraction σij of individuals infected with j become completely immune to i (i.e., 
transition directly from Si to Ri) while the others remain susceptible to i. In this model, 
cross-immunity is symmetric, σij = σji.  
Individuals infected with strain i transition sequentially and at a constant, strain-
specific rate νi through four compartments, Ii,1…Ii,4. (We use Ii to refer to the sum of all 
individuals across these compartments.) The total rate of recovery is thus given by νi/4. 
Using multiple compartments allows a more realistic duration of infection; the single-
compartment model (Ii = Ii,1) gives an exponential distribution of waiting times, whereas 
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the four-compartment model yields a four-category gamma distribution that better 
matches empirical observations (Carrat et al. 2008).  
The transitions between states are modeled stochastically as whole numbers of 
individuals. The model thus incorporates demographic stochasticity and allows for local 
extinctions. Simulations occur in discrete time with a step size of one day. 
 
Measurement model 
If all infections resulted in perfectly observed hospitalizations, simulated monthly cases 
for each strain i would equal the total number of Si → Ii,1 transitions of that month, Ci. 
The observed cases in the data are confirmed new hospitalizations with each strain i. We 
thus introduce a strain-specific hospitalization rate, hi. We assume the number of 
observed cases is drawn from a negative binomial distribution with mean hiCi and a 
strain-specific dispersion parameter, di. The simulated observations, Yi, are thus given by 
 
Yi ~ negative binomial(hiCi, di). (4.4) 
 
Since the negative binomial distribution can be derived from a Poisson distribution with 
nonstationary mean, it is well-suited for data in which sampling effort or virulence may 
have changed over time, but in which more complicated functions might lead to 
overfitting. 
 
Fitting algorithm and heuristics 
To fit the parameters, we use a flexible method for maximum likelihood estimation of 
partially observed, nonlinear dynamical systems (Ionides et al. 2006). The method 
iteratively filters a particle population over the set of observations. Each particle 
represents a possible numerical solution (i.e., set of parameter values, including initial 
values of the state variables) to the model. With a sufficiently large particle population 
and appropriate exploration and cooling parameters, this method has been shown 
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theoretically to converge on the MLE (Ionides et al. 2006). In practice, it has yielded 
plausible results for a single-strain system (King et al. 2008).  
In applying this method, we make minimal assumptions about our parameters. In 
addition to the known birth and death rates and the fixed immigration rate m, we force 
IH1N1 = 0  at the beginning of the simulation (January, 1969) and introduce it through 
immigration in October of 1977. We also begin the simulation with total population size 
N = 3,859,358, obtained from Soviet census data. Between 1969 and 1977, individuals 
that start the simulation recovered to H1N1 do not lose their immunity, except through 
death. This assumption is in keeping with the observations that H1N1 was extinct in 
humans between 1957 and 1977, that the 1977 strain showed minimal genetic distinction 
from a strain in 1950 (Scholtissek et al. 1978), and that people are capable of maintaining 
strong neutralizing antibody responses to H1N1 strains decades after exposure (Kendal et 
al. 1979; Yu et al. 2008). 
 
Results 
Assuming no cross-immunity between the strains yields a R0 of 8.6 for H3N2, 3.4 for 
influenza B, and 9.4 for H1N1 (table 3.1). The seasonal forcing ε is approximately 0.13, 
and thus the R0 of all strains exceeds one throughout the year. Hosts’ durations of 
immunity are shortest in B (~1.25 years) and longer in H3N2 and H1N1 (~3 years). 
Hospitalization rates per infected are greatest in H3N2 (hH3N2 = 1.3 ⋅ 10-3) and 
approximately half as large in B and H1N1, and the inferred distributions are 
overdispersed (2.6 < di < 4.0). Immunity levels in 1969 were highest to H1N1, next 
highest to H3N2, and third highest to influenza B. 
The model with cross-immunity had significantly higher likelihood (table 3.1). 
The best fit reported cross-immunity of roughly 0.76 between H3N2 and influenza B and 
cross-immunities of 0.36 between H3N2 and H1N1 and 0.39 between B and H1N1. 
Compared to the null model, values of R0 were generally lower (4.1 for H3N2, 5.2 for B, 
and 6.5 for H1N1) and hospitalization rates were higher (0.49 ⋅ 10-3 – 2.5 ⋅ 10-3) and 
generally less overdispersed (2.3 < di < 6.1). The durations of immunity were shorter, 
roughly 1.6 to 2 years, and not correlated in an obvious way to R0. Initial values of the 
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state variables were similar to the null model’s for H3N2 and H1N1, though initial 
immunity levels were higher for influenza B. The seasonal forcing parameter ε was 
almost identical to that of the null model. In most simulations with the fitted parameters, 
H1N1 was unable to invade or appeared after the 1977-1978 season (figure 3.2).  
 
Discussion 
We analyzed time series of serologically confirmed hospitalizations in St. Petersburg, 
Russia, over two decades to obtain basic information about the epidemiologic rates of 
influenza A H3N2, H1N1, and influenza B. We also sought to determine whether there 
was dynamical evidence of cross-immunity between types or subtypes. When we fit a 
model that assumes all strains have independent dynamics, except for shared seasonal 
forcing and a very low immigration rate, the results yield high values of R0 and low rates 
of antigenic evolution in H1N1 and H3N2 and a much lower R0 and higher rate of 
antigenic evolution in influenza B. This result suggests identifiability problems between a 
strain’s R0 and its rate of antigenic evolution. The model without cross-immunity 
outperformed the model with cross-immunity, inferring lower values of R0 and smaller 
differences among the strains. Simulations from this model frequently do not allow 
invasion by H1N1, however. Its performance nonetheless suggests some basis for 
believing some degree of cross-immunity is likely, especially between H3N2 and B, but 
more investigation is necessary. 
The model without cross-immunity is consistent with other estimates of 
hospitalization and mutation rates, though its predictions for R0 are slightly high. Typical 
hospitalization rates for the general population in the U.S. have been estimated at 108 per 
100,000 among children less than five years old and 20 per 100,000 person-years for 
children between 2 and 5 years old [reviewed in Fiore et al. (2008)]. With a 10% annual 
attack rate (Cauchemez et al. 2008), the per-case hospitalization rate would be on the 
order of 10-3 for the general population. The differences inferred in hospitalization rates 
between strains echo differences in observed mortality rates, which are generally lower 
for H1N1 and B than H3N2 (Fiore et al. 2008). Mutation and substitution rates are higher 
in influenza A than B viruses (Nobusawa & Sato 2006), and antigenic evolution is faster 
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in H3N2 than H1N1 (Rambaut et al. 2008). Epidemic- and season-specific reproductive 
numbers are more commonly estimated than direct estimates of R0, and the majority 
suggest a seasonal reproductive number between 1 and 2 (table 3.S1). Direct estimates of 
the R0 of H1N1 (Mills et al. 2004) and H3N2 (Gani et al. 2005) are lower than those 
reported here. The reproductive number of influenza B does not appear to have been 
estimated before. Time series of deaths to influenza-like illness from before 1957 suggest 
that the R0 of influenza B is on par with that of H1N1 [e.g., Viboud et al. (2006b)]. 
Though this model may be considered large for containing 24 parameters 
(including initial values), it makes simplifying assumptions that might be important for 
understanding the dynamics of seasonal influenza. Probably the most important of these 
assumptions involve the nature of antigenic evolution and the effects of host age. Abrupt 
changes in antigenicity that cause spikes in incidence have been observed in H3N2 
(Greene et al. 2006; Smith et al. 2004) and attributed to epochal evolution (Koelle et al. 
2006). It is not clear, however, clear whether antigenic innovations should be represented 
by stochastic fluctuations in the rate of loss of immunity instead of the rate of 
transmission. A serial SIR formulation that represents the major antigenic variants within 
each subtype independently may be more appropriate (Koelle et al. 2009).  
The data also reveal striking patterns in attack rates of each type and subtype by 
age (figure 3.S1), suggesting that an age-structured model might be useful in 
disentangling parameters. H3N2 and B show years of alternating dominance in adults, but 
years in which H3N2 dominates in adults also show inordinate spikes in prevalence in 
infants and young children. In contrast, the prevalence of B in infants and young children 
shows less intraannual and interannual variability, whereas older children show 
interannual oscillations similar to adults. H1N1, unlike H3N2 and B, does not show 
substantial variation in prevalence from year to year, and it is rarely the most common 
strain among ILI hospitalizations in any season. 
These trends have not yet been quantitatively analyzed with more complex 
models. Nonetheless, our results so far suggest a (still highly speculative) qualitative 
explanation. Abrupt antigenic changes should be associated with a sudden loss of 
immunity independent of host age (Cobey & Koelle 2008). Punctuated antigenic 
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innovations in H3N2 could thus explain why spikes in prevalence appear simultaneously 
in all age classes, including infants (whose maternal antibodies to H3N2 will also fail). 
Some combination of more gradual antigenic change and potentially reduced R0 of 
influenza B and H1N1 account for the higher average age of infection and the lack of 
synchronous spikes across age classes. Years in which influenza B dominates in adults 
thus would not result from significant antigenic change in B (which would cause a large 
outbreak in children) but from transiently reduced competition with H3N2. Others have 
suggested that competition could account for recent variation in dominance between 
H3N2 and H1N1 (Ferguson et al. 2003; Rambaut et al. 2008; Wolf et al. 2006). 
This model makes assumptions about cross-immunity that are not necessarily 
justified or relevant to current dynamics. We assume that cross-immunity between 
heterologous types or subtypes is symmetric, though there is evidence that cross-
immunity between strains of a single subtype can be asymmetric (Underwood 1980). 
Future work could include fitting a model for each directed pairwise interaction. Since 
strain-specific antibodies are the main selective pressure driving the evolution of H3N2 
and presumably B (Chen & Holmes 2008; Shen et al. 2009) and H1N1 (Raymond et al. 
1983) [but see Nelson et al. (2008) and Chen & Holmes (2008) for evidence that 
selection on whole reassorted genomes may be important], our model also assumes 
permanent strain-specific immunity. However, others have suggested the possibility of 
transient, strain-transcending immunity, which might be mediated by cellular immunity 
(Ferguson et al. 2003). The strength, specificity, and kinetics of T-cell responses are not 
well understood, but this might be an alternative or additional mechanism through which 
cross-immunity acts. We might also expect cross-immunity to change over longer time 
scales: strains that do not share common epitopes should have a selective advantage over 
those that do. Thus, cross-immunity might have existed between H3N2 and B in the 
1970s but not in the 1980s or presently.  
The complexity of the dynamics that can be generated by an interacting three-
strain, seasonally forced disease is formidable. Because even an single, seasonally forced 
SIRS model can generate chaos, and the starting conditions in 1969 are not well known, 
the conclusions that can be inferred from a single time series are inherently limited. 
Supplementing this analysis with time series from other locations, information on hosts’ 
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immune statuses, quantitative measures of antigenic change, and especially specific 
hypotheses about possible mechanisms of cross-immunity should lead to the development 
of predictive models and better insights for managing influenza.
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Figure 3.1. Hospitalizations with serologically confirmed influenza and interpolated birth 






Figure 3.2. Simulated time series from the fit of the model with cross-immunity. In this 




Table 3.1. Fitted parameters in models with and without cross-immunity.  
 
 No cross-immunity Cross-immunity 
Log likelihood   
ε 0.13 0.14 
σH3N2,B - 0.75 
σH3N2,H1N1 - 0.36 
σB,H1N1 - 0.39 
H3N2   
R0 8.6 4.1 
γ  0.32 y-1 0.61 y-1 
φ 0.15 0.068 
h 1.3 ⋅ 10-3 y-1 2.5 ⋅ 10-3 y-1 
d 3.2 5.3 
S(0)/N(0) 0.12 0.17 
I(0)/N(0) 0.20 0.13 
R(0)/N(0) 0.68 0.60 
B   
R0 3.4 5.2 
γ  0.79 y-1 0.48 y-1 
φ 0.055 0.090 
h 0.49 ⋅ 10-3 y-1 1.6 ⋅ 10-3 y-1 
d 2.6 6.1 
S(0)/N(0) 0.17 0.09 
I(0)/N(0) 0.17 0.04 
R(0)/N(0) 0.66 0.87 
H1N1   
R0 9.4 6.5 
γ  0.29 y-1 0.58 y-1 
φ 0.20 0.098 
h 0.74 ⋅ 10-3 y-1 0.49 ⋅ 10-3 y-1 
d 4.0 2.3 
S(0)/N(0) 0.08 0.06 
R(0)/N(0) 0.92 0.95 
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Supplementary material 
As this method is still relatively new, we briefly summarize heuristics that were more and 
less useful for fitting. For each of the models with and without cross-immunity, we first 
performed a sweep of approximately one million points in parameter space, filtering once 
at each point with only a small number of particles. We then started two sets of larger 
populations (of initially 104 particles each) at the forty best points. Each set was assigned 
a different standard deviation in their random walks (standard deviation of 0.05 or 0.1) 
and high between-iteration variance (variance factor = 1.3) in attempt to find a 
compromise between speed and accuracy. In rugged areas, populations with a standard 
deviation of 0.1 could actually lose information and begin declining in likelihood. In 
smoother areas, these populations were able to climb dramatically faster than populations 
with a random walk of 0.05. However, since many of the populations’ trajectories pass 
through rugged areas, the best long-term strategy is probably to allow populations to 
climb slowly with a small standard deviation. The density of the particle population is 
also critically important and interacts with the standard deviation of the random walk. 
Information is more easily lost when Monte Carlo error (from demographic stochasticity 
of the particles) is high. Some of the effects of large standard deviation can thus be 
ameliorated by substantially increasing the population size. Developing an algorithm that 
incorporates an adaptive standard deviation and/or particle density might be a useful 
means to increase efficiency. 
We allowed populations to climb without cooling for 300-400 iterations and then 
slowly cooled for 200-250 iterations with a lower between-iteration variance (cooling 
parameter = 0.995, variance factor = 1.1). Beyond using multiple standard deviations, we 
found no advantage to replicating the iterations, as populations’ trajectories through 
parameter space were similar. However, all trajectories had not converged by the end of 
our procedure, demonstrating that our MLEs are effectively local and that our heuristics 
can be refined. Especially for the model with cross-immunity, 104 particles is probably 
too few. While this density was sufficient in some parts of parameter space, the large 
Monte Carlo error in others probably distorted its trajectory. Future work will focus on 
fitting with larger particle densities (30,000 and higher) and small-deviation random 
walks (0.05 and below). In addition, it is probably advantageous to restrict the flexibility 
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of the measurement model, specifically by bounding the dispersion parameter. Final 
confirmation of maxima will of course require extensive likelihood profiling. 
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Table 3.S1. Values of influenza’s intrinsic reproduction number, R0, and effective 
reproduction number, Rp, inferred by other studies. R0 measures the expected number of 
secondary cases in an entirely susceptible population. Rp measures the expected number 
of secondary cases at the beginning of an epidemic, assuming some level of immunity in 
the population. If the strains are “mixed,” then the study did not infer quantitative, type- 
or subtype-specific estimates of R0 or Rp. ILI = outpatient visits with influenza-like 
illness; P&I = pneumonia and influenza. 
 
 
R0 (Rp) Strain(s) Time Location Data Reference 
 Interpandemic influenza  
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(2008) 





















Viboud et al. 
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Table 3.S1. (continued) 
 
R0 (Rp) Strain(s) Time Location Data Reference 
(2.1) H1N1 1918 
(1.5) H2N2 1957 
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The consequences of strain competition have major implications for vaccination 
strategies and assessments of epidemic risk. Models of strain competition often implicitly 
assume that cross-immunity between strains is invariant among hosts: If hosts have the 
same infection history or immune repertoire, they share the same probability of being 
infected or infectious upon challenge with a new strain. Cross-immunity under this 
assumption can yield complex dynamics determined by the intensity of competition 
(Gupta et al. 1998). For realistic ratios of infection times and host lifespans, three general 
outcomes are possible. Intense strain competition leads to minimal diversity: All strains 
die out except a subset of discordant phenotypes. At intermediate competition, groups of 
discordant strains undergo cyclical or chaotic dynamics, causing diversity to vary in time. 
When cross-immunity is low, strains can coexist at an endemic equilibrium. These 
outcomes imply dramatic differences in the number of circulating strains and how the 
pathogen population might respond to immigration or mutation. 
 Recent models of influenza’s dynamics find that some level of cross-immunity 
between strains is essential to constrain diversity to observed levels. Several posit that a 
necessary element of strain competition is a many-to-one mapping between individual 
strains, defined by their amino acid sequences, and their antigenic phenotypes (Ferguson 
et al. 2003; Gog & Grenfell 2002; Gokaydin et al. 2007; Koelle et al. 2006; Tria et al. 
2005). These models assume to varying degrees that the cross-immunity between any two 
strains is static. There are reasons why this assumption might not hold in nature, 
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however. Several biologically plausible mechanisms exist that might allow a genotype to 
map to more than one phenotype, producing a multidegenerate genotype-phenotype map. 
Put simply, hosts with the same infection history or immune repertoire could then 
perceive genetically identical strains differently.  
This study is an initial foray into the consequences of competition between strains 
when their phenotypes can vary among hosts. We begin by reviewing evidence for 
various mechanisms of heterogeneity in host responses, with an emphasis on influenza. 
We then present our model, which incorporates only the simplest level of heterogeneity. 
Our general result is that coexistence of strains is easier when responses at the individual 
level are narrow, and when responses at the population level are very diverse or 
homogeneous. It will thus be important to show that models of strain extinction through 
immune-mediated competition are either robust to this heterogeneity, that these 
differences disappear with further incorporation of biological detail, or that typical 
immune responses are quite broad. Our conclusions suggest there might be general 
differences in the competitive regimes faced by strains under selection from cellular 
versus antibody-mediated immunity.  
 
Diversity in host responses 
Different immune responses have been observed in humans infected with the same strains 
of influenza. Nakajima et al. (2000) found age-related patterns in the acute phase and 
convalescent sera of nine people infected with H3N2 during the 1990-1991 season. The 
sera of the three and four year old children had antibodies only to site B1, and all the 
older children and the one adult had antibodies binding to sites A, B1, B2, C, and C/E. In 
a follow-up study, Sato et al. (2004) examined the sera of 35 people who had been 
infected with a strain of the SY97 cluster and found that almost all young children 
developed antibodies to B1 and many to A. Older children and adults developed unique 
polyclonal responses involving several antibodies, often reacting more strongly to 
epitopes other than B1.  
These patterns might arise from differences in past infection history, with 
polyclonal responses becoming more common as antibodies to formerly encountered 
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epitopes accumulate. There are several lines of evidence suggesting that additional 
dynamics might be involved. Hosts that have encountered the same sets of strains can 
respond differently depending on the order in which strains were encountered, a 
phenomenon known as original antigenic sin (OAS) (Francis 1960; Hoskins et al. 1979; 
Smith et al. 1999) (figure 4.1a). If strains x, y, and z are arranged consecutively along 
linear antigenic space, a host with immunity to strain x might reuse its antibodies to x 
when exposed to strain y (thereby avoiding infection or reducing infectiousness with y) 
and then be relatively defenseless upon encountering strain z. A host that encounters 
strain y first could, in contrast, be partially protected against both x and z.  
Another source of differences can arise from variable immunodominance, which 
might operate alone or with OAS. The study by Sato et al. (2004) found that while two 
epitopes seemed especially immunogenic (attractive to antibodies) in children, the 
relative strengths of their antibodies to each epitope could be very different. Children 
with a stronger response to epitope B1 might thus react differently to future strains than 
children with a stronger response to epitope A. These differences might simply reflect the 
signature of OAS—B1 may be immunodominant, but some children had encountered 
epitope A before—but differences might arise even if the subjects’ immune repertoires 
are identical. Experimental infections of influenza in naïve animals have shown that hosts 
can vary in which epitopes they target, and that when targeting the same epitopes, hosts 
often have quantitatively different responses (Cleveland et al. 1997; Laver et al. 1976), 
though some strains and/or host genotypes might generate more uniform responses 
(Lambkin & Dimmock 1995). Differences in host responses might be random, perhaps 
dependent on which B cells (which generate antibodies) and helper T cells (which 
stimulate select B cells) encounter epitopes first, or which B cells have the highest avidity 
for their epitope (figure 4.1b). These differences might on some level be predetermined. 
An individual’s MHC alleles determine which T-cell epitopes (including those of helper 
T cells and CD8+ cells, which underlie cellular immunity) are recognized by the immune 
system. T-cell immunodominance hierarchies further appear to depend in a nontrivial 
way on the identities of other MHC alleles in individual hosts (Boon et al. 2004) and in 
some cases on which other T-cell epitopes are present (Jenkins et al. 2006). It might be 
possible that MHC class-II alleles, which are essential for B cell selection, could 
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predispose hosts for particular humoral responses (Crowe et al. 2006). Thus, hosts might 
fall into groups depending on which epitopes they are genetically predisposed to 
recognize (figure 4.1c). 
Still other differences in host response are possible. For example, two hosts 
reacting to the same antigen can form antibodies with different potentials for cross-
reactivity (Fleury et al. 2000). Strain dynamics might be further complicated by 
asymmetry in cross-immunity: Antibodies against x may be more effective against y than 
antibodies to y are against x (Underwood 1980). The strength of immune responses to 
particular epitopes might decay in time (Nowak et al. 1995).  
This analysis ignores these possibilities and begins with a population of 
intrinsically identical hosts. Our only assumption is that epitopes compete for 
immunodominance. Not all hosts infected with the same strain will recover with 
antibodies to every epitope, but which epitope(s) a host develops immunity to is 
randomly determined.  
 
Model 
We begin by describing a general model of strain competition by Gupta et al. (1998) and 
then introduce our adaptation for heterogeneous host responses.   
 Strains have n loci, each defined by m possible alleles (Gupta et al. 1998). Each 
locus corresponds to an epitope, and each allele a possible phenotype of the epitope. 
Cross-immunity is set by γ, which gives the reduction in transmission probability 
conferred by previous infection with one strain; (0 ≤ γ ≤ 1). Without heterogeneous 





= (1" zi)#i "µzi , (5.1) 
 
where λi is the force of infection of strain i (the per capita rate of rate of acquiring 
infection, which is linearly proportional to the number of infectious individuals), µ is the 
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birth and death rate, and (1 − zi) is the fraction of the population not immune to strain i 
from infection with i. An assumption of this model is that immunity to i is conferred 
immediately upon infection with strain i. Variable zi thus represents cumulative incidence 
of i: it increases from direct infections with i and decreases only through mortality. 
Compartment wi represents hosts immune to all strains j that share alleles with i, 





= (1" wi) #j
j~ i
$ "µwi , (5.2) 
 
The expression j ~ i refers to all strains j sharing alleles with i, and (1 − wi) is the fraction 
of the population that has never been infected with a strain that shares alleles with i. The 
difference between zi and wi is that the former acquired immunity to i from infection with 
i, and the latter acquired immunity to i via infection with strain j that shares alleles with i. 
Thus, zi is a subset of wi. The wi compartment thus tracks cumulative immunity to i, 
including in individuals currently infectious with i and in individuals who were never 
infected with i but who attained immunity through infection with j. 





= [(1" wi) + (1" #)(wi " zi)]$i "%yi , (5.3) 
 
where σ is the rate of recovery. The quantity (wi − zi) is individuals who acquired 
immunity to i through infection with a different strain. Equations 5.2 and 5.3 show that 
cross-immunity in this model acts through a reduction in infectiousness: fraction γ of 
individuals who are immune to i from infection with a different strain, γ (wi − zi), cannot 
become infectious with i (though these individuals still become infected as zi). The 
remaining fraction, (1 − γ)(wi − zi), can become infectious with i, as can those individuals 
who have never been infected with a strain sharing alleles with i, (1 − wi). Thus, yi is a 
subset of wi and zi. 
 89 
 To incorporate host heterogeneity into this formalism, we account for the 
possibility that hosts might not identify shared epitopes between strains due to 
immunodominance. In other words, infection with strain j will not automatically confer 
immunity to strain i simply because the two strains share common epitopes. An 
additional requirement must be met, which is that the shared epitope must have triggered 
a strong immune response during infection with strain j. Let pn be the probability that 
individuals develop an antibody to epitope n; pn thus measures the epitope’s 
immunodominance. Initially, we assume all responses are on average monoclonal to one 
epitope, so that Σ pn = 1. Equation 5.1 does not change: all people infected with strain i 
will mount a specific response to one of its epitopes and will not transmit i in the future. 
But now not all hosts with immunity to strain j, which shares epitopes with i, will have 
immunity to i. Only the fraction of hosts infected with j that mount antibodies to epitopes 
shared with i will then be immune to i. Let Sij be the set of shared epitopes between 





# , (5.4) 
  




= (1" wi) #j
j
$ rij "µwi, (5.5) 
 
We retain the assumption that there can be reduction in infectiousness γ between immune 
responses to i and j. Equation 5.3 thus remains the same.  
Our analysis focuses on the effects of changing epitopes’ immunodominance. 
Values of pn are drawn from a normalized negative binomial distribution, which can 
allow every epitope to have the same immunodominance or for the probabilities to be 
highly skewed (supplementary material): skewed distributions correspond to less diverse 
immune responses at the population level and even distributions to more diverse 
responses. We initially assume that hosts retain immunity on average to only one epitope 
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(figure 4.2). Mathematically, this is equivalent to Σ pn = 1. We then allow polyclonal 
responses (Σ pn > 1) to the limit where infected hosts always develop immune responses 
to all epitopes, Σ pn = n. To increase the breadth of the antibody response, we multiply 
each response pn by a “polyclonality” factor c, which ranges from 1 to n, and further 
require pn ≤ 1. The ordinary differential equations were simulated numerically for the 
three locus (n = 3), two allele (m = 2) case (supplementary material). 
 
Results 
With a monoclonal response, the interesting dynamical regimes disappear (figure 4.3a). 
After initial oscillations, strains coexist at an endemic equilibrium, comparable in 
prevalence to the regime of low cross-immunity in the original model (figure 4.3b). This 
pattern results regardless of the relative immunodominance of the different epitopes.  
 When hosts recognize more epitopes (c > 1), the complex dynamical behavior at 
high levels of cross-immunity returns. When hosts recognize on average half the epitopes 
(c = 1.5), increasing the cross-immunity above approximately 0.7 (at b = 0, where all 
epitopes have equal probability of dominating) results in the onset of chaotic dynamics, 
followed by (from approximately 0.9 < γ ≤ 1) a regime of competitive exclusion and the 
dominance of one antigenically discordant set (figure 4.4). As the immunodominance 
distribution becomes more skewed (b = 1/3, b = 2/3), the chaotic dynamics expand to 
slightly higher γ and are preceded by a growing region of limit cycles. Extreme limit 
cycles also appear for high γ after the chaotic region for b = 2/3. Thus, increasing the 
skewness of the immunodominance distribution (but with b < 1) generally increases the 
region of cyclic and chaotic behavior.    
 Previous analyses have found a boundary between discrete strain structure, in 
which one discordant set dominates, and regimes of no, chaotic, or cyclic strain structure 
(Gupta et al. 1998; Recker & Gupta 2005). Increasing the breadth of the immune 
response even further (c > 1.5) expands the regions of cyclic, chaotic, and competitively 
exclusive behavior; all start at lower γ (figure 4.5 and figure 4.S1). The effects of 
changing the skewness, b, do not qualitatively differ as immune responses broaden from 
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c = 1.5 to c = 3. Since the dynamics analyzed in the original model (Gupta et al., 1998), 
correspond to the case where c = 3 and b = 0, our results show that reducing the breadth 
of the immune response (c < 3) increases the minimum cross-immunity required for the 




Experiments with influenza in several host species suggest that hosts that have been 
exposed to the same strains will not necessarily develop the same immune repertoires, 
and hosts with identical immune repertoires will not necessarily respond identically upon 
infection with the same challenge strain. Understanding the outcome of strain 
competition is the motivation for many models of infectious disease, and yet the majority 
of models are grounded on simple and largely unquestioned assumptions about the nature 
of cross-immunity [cf. Kryazhimskiy et al. (2007)]. The aim of this study was to 
minimally relax a common assumption. We found that when hosts randomly varied in 
which epitopes they developed immunity to, coexistence among strains was more 
common. In particular, narrow immune responses that were focused on one epitope on 
average weakened competition so much that strains could coexist for any level of cross-
immunity and any amount of diversity in the host population. As the breadth of the 
immune response increased, competition intensified. Limit cycles, chaos, and competitive 
exclusion then became possible at high levels of cross-immunity. 
Other models have explored the consequences of heterogeneous host immune 
responses for strain competition and obtained complementary results. Gupta and Galvani 
(1999) considered a population of two host genotypes. Genotype “A” followed the 
dynamics outlined in the original model (equations 5.1-5.3) and genotype “B” recognized 
a locus common to all strains (i.e., perceived all strains as identical). Increasing the 
proportion of genotype B hosts gradually reduced the threshold level of cross-immunity γ 
required for strain structure to appear and increased the period of oscillations of 
discordant antigenic sets. In populations comprised solely of genotype B hosts, 
oscillations disappeared, and the strain with the highest R0 dominated. Thus, increasing 
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the intensity of strain-transcendent competition (the fraction of genotype B hosts) 
reduced strain diversity, and the presence of hosts capable of strain-specific responses 
increased diversity. This result is consistent with the effects of generalized immunity, a 
transient strain-transcendent immunity that was found to dampen diversity in simulations 
(Ferguson et al. 2003). 
The assumptions of a model by Recker and Gupta (2005) are closer to the ones 
here. Rather than assuming that the degree of cross-immunity between two strains was 
independent of the number of shared epitopes (assuming the strains share at least one), 
they introduced another class of individuals immune to any strain k that shares more than 
one allele with strain i. Individuals immune to i via prior infection with k have a greater 
reduction in infectiousness (higher cross-immunity, γ2) than individuals immune to i via 
prior infection with strains sharing only one allele with i (with cross-immunity from the 
latter given by γ1, and γ1 < γ2). A high degree of cross-immunity between more closely 
related strains, γ2, could precipitate the onset of the transition to discrete strain structure 
even when γ1 was relatively low. In other words, including some immunological 
precision about the extent of phenotypic similarity could restrict diversity further over the 
original model. 
 Several caveats are required to place this work in theoretical context. Our model 
suggests that such restrictions found by Recker and Gupta (2005) depend on the breadth 
and diversity of the immune response. Dynamically, changing c, the breadth of the 
immune response, appears to have similar effects on dynamics to changing the number of 
immunodominant epitopes, n (Gupta et al. 1998). Our model is also convergently similar 
in structure to models based on polarized immunity (Gog & Swinton 2002): Rather than 
cross-immunity acting through a partial reduction in infectiousness or susceptibility in all 
immune hosts, strain competition is effected when some fraction σij of hosts infected with 
j develops immediate immunity to i. If γ = 1, we obtain a model of polarized immunity 
with σij = rij, the effective similarity of the strains’ phenotypes. When γ < 1, our model 
effectively allows cross-immunity to epitopes shared by strains i and j to be imperfect. To 
our knowledge, the status-based approach has not previously been described or applied in 
the context of immunodominance and natural heterogeneity in host responses.   
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 Careful investigations are warranted in translating these results to practical 
biology. The summaries here are of equilibrium conditions, deterministically obtained, 
and ignore extinctions that would result from demographic stochasticity. Less obviously, 
our model, like models of polarized immunity, assumes it can represent the effects of 
many probabilistic outcomes (response versus non-response to epitopes by individual 
hosts) as average rates. Our model should thus contain less variance in host immunity 
than one might observe in an agent-based representation of this system. Such differences 
might be dwarfed by inclusion of more realistic mechanisms, such as the degree to which 
individuals may be genetically predisposed to respond to particular epitopes. Another 
potential area for investigation is whether differences arise in primary versus secondary 
responses (Crowe et al. 2003; Lambkin & Dimmock 1996). 
Our findings underscore that research into the specificity, dynamics, and 
especially breadth and diversity of human immune responses to influenza will be 
important for developing accurate models. Since T-cell epitopes are recognized by a 
limited set of MHC alleles, whereas B cell adaptation is relatively unrestricted, we might 
expect greater coexistence of antigenically diverse strains in pathogen populations that 
compete mainly against hosts’ cellular immunity. As pathogens are under selective 
pressure to minimize their numbers of immunogenic, neutralizing epitopes, the potential 
breadth of immune responses might also change in time. Understanding the breadth of 
immune responses will also be important to understand how mutants appear and spread. 
Nakajima et al. (2000) and Sato et al. (2004) posit that antigenic drift results from serial 
adaptation to monoclonally-responding subpopulations. For example, variants first escape 
site B1 and then sites targeted by others. Cleveland et al. (1997) recalled that major drift 
variants tend to have at least four amino acid substitutions in two epitopes (Wilson & 
Cox 1990). They predicted the existence of four different “human genetic groupings” 
with consistent, nonoverlapping epitope biases. Viruses drift as they move from group to 
group, acquiring a critical amino acid change in each, and become double escape 
mutants. In contrast to Sato et al. (2004), they argue that polyclonal responses can select 
for drift mutants under particular conditions. Other models in mice and ferrets suggest 
that mutants can arise from polyclonal responses as long as they could escape a 
predominant antibody [reviewed in  (Nakajima et al. 2000)]. 
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This work shows how consumer-resource dynamics can be qualitatively affected 
by the phenotypic resolution of one of the parties (here, the pathogen consumers). 
Dynamics may be more interesting still if the phenotypic resolution depends specifically 
on intrinsic properties of the resource, as when pathogens compete against MHC-
restricted T-cell epitopes. We have highlighted several hypotheses of strain competition 
relevant to influenza, and which deserve further analytic and empirical investigation. 
Accurately predicting the outcome of strain dynamics will require choosing carefully 











Figure 4.1. Three possible mechanisms of heterogeneity in hosts’ immune responses. 
Hosts are immunologically naïve before the first challenge. Each shape/location in a 
strain corresponds to an epitope/locus; each color corresponds to a different 
phenotype/allele at that epitope/locus. Symbols crossed in red represent specific adaptive 
immune responses (e.g., antibodies or T cells) to that particular phenotype/allele. (a) 
Original antigenic sin (OAS). OAS posits that strains that are closely antigenically related 
may not inspire novel immune responses. Thus, hosts exposed to the same strains but in 
different sequences will accumulate different immune repertoires and can respond 
differently upon infection with the same challenge strain. This example shows OAS with 
a multilocus and polyclonal response; it can also operate for a single locus and 
monoclonal response. (b) Random immunodominance. This mechanism, the basis of the 
model explored in this paper, assumes that hosts usually only perceive or develop a 
strong response to a subset (here, one) of available epitopes. Epitopes have certain 
probabilities of being immunodominant, and these probabilities do not vary among hosts. 
(c) Predetermined immunodominance. Hosts intrinsically vary in their propensities to 
mount immune responses to different epitopes. Host A recognizes only the first locus, 






















Figure 4.2. Distributions for pn, the probability of developing an immunodominant 
response to epitope n, for the model where n = 3. Parameter c gives the breadth of the 
response: c = 1 corresponds to a monoclonal response and c = n the maximum polyclonal 
response. Parameter b gives the skewness: b → 0 yields equal pn, and b → 1 yields p1 → 






Figure 4.3. Dynamics with monoclonal immune responses (c = 1). (a) Equilibrium strain 
dynamics. (b) Sample time series showing transients of zi, wi, and yi with γ = 0.75 and b = 
1/3. Each color corresponds to a different strain. Note differences in the ranges of the y-













Figure 4.4. Dynamics under incomplete polyclonal immune responses (c = 1.5). (a) 
Equilibrium strain dynamics. Diagram for b = 1 is identical to figure 4.3a. (b) Sample 
time series showing transients of zi for different values of γ; b = 1/3 or b = 2/3. Each color 















Figure 4.5. Dynamics under full polyclonal immune responses (c = n = 3). (a) 
Equilibrium strain dynamics. Diagram for b = 1 is identical to figure 4.3a. (b) Sample 
time series showing transients of zi for different values of γ; b = 1/3 or b = 2/3. Though 



















The negative binomial distribution is typically written as  
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f (k; r, p) =









(1" p)k , (5.S1) 
 
where 0 < p < 1 and r > 0. To avoid confusion with epitope immunodominance, we refer 
to p above as b. We set r = 1. The per epitope immunodominance pk is 
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where k refers to the epitope (k ∈ {1,…,n}) and c is the degree of polyclonality (main 
text). To accommodate b = 0 and b = 1, we approximate completely flat and skewed 
distributions with b =  10-10 and b = 1−10-10, respectively.  
 
Parameters 
All rate parameters are the same as those used in Gupta et al. (1998): birth and death, µ = 
1/50 y-1; recovery, σ = 10 y-1; R0 = 4. Values of yi(0) were drawn from a uniform random 
interval over (0, 0.25], and yi(0) = zi(0) = wi(0). These random starting conditions were 
used for each of the sample time series shown in figures 5.3b, 5.4b, and 5.5b and also for 
each bifurcation diagram at γ = 0.5. For subsequent values of γ in the bifurcation 
diagrams, initial values were copied from the final values simulated for the previous 
value of γ. 
 
 106 
Numerical solution of the ordinary differential equations 
We used a fourth- and fifth-order Runge-Kutta solver implemented in Matlab (function 
ode45) with absolute and relative error tolerances of 10-6. Simulations were run for 5000 
years and then sampled for the next 1000 years. The diagrams show all maxima and 
minima over the sampling period. These inflection points were obtained using Matlab’s 




Figure 4.S1. Equilibrium dynamics under incomplete polyclonal immune responses (c = 
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Ecological factors driving the long-term evolution  




Several challenges complicate the task of predicting evolution. One is the presence of 
evolutionary constraints: It might not be possible to optimize two phenotypic traits 
simultaneously, because a high value in one trait rules out high values in the other. 
Another problem concerns attainability: Evolutionary pathways may lead through regions 
of low fitness or, if mutations interact epistatically, may be difficult to map. Yet another 
class of problems arises from the environment or ecology in which evolution occurs: The 
fitness of a trait may be frequency-dependent, being determined by the phenotypes of 
other individuals. Fitness can also be affected by population size, spatial interactions, and 
extrinsic factors, and these relationships can be nonlinear and dynamic. 
 Predicting evolution of host ranges in pathogens requires confronting several of 
these problems at once. Many pathogens show adaptation to specific host or tissue types 
and are unable to infect other hosts or tissues without undergoing extensive adaptation 
(Baranowski et al. 2001; Webby et al. 2004). Such adaptation often comes at the expense 
of the ability to infect an original host type, and thus presents an evolutionary constraint 
in the form of a tradeoff. Pathogens tend to undergo extreme changes in population size 
during the same period in which rapid evolution occurs. Host immunity furthermore often 
imposes frequency-dependent selection. 
 Given this complexity, it is not surprising that there is little overarching theory for 
understanding the evolution of host ranges in pathogens. This is unfortunate, considering 
the ubiquity of zoonoses: Most pathogens of humans infect at least one other species 
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(Woolhouse & Gowtage-Sequeria 2005). Existing models address host range indirectly. 
For example, Parker (2003) used optimization principles to show how parasitic 
helminthes might expand their host range through trophic transmission to acquire 
complex life cycles. Gandon (2004) developed predictions for the evolution of virulence 
and transmission in a multihost environment. Some insights might also be gained by 
interpreting host range as a resource-choice problem for pathogens. In Levins’s (1962) 
classic approach, consumers are predicted to specialize under strong tradeoffs and to 
adopt generalist strategies when tradeoffs are weak. His model, like Parker’s, assumes 
that the optimal strategy will prevail. When selection is frequency-dependent, however, 
optimization principles are likely to give qualitatively incorrect predictions (Dieckmann 
et al. 2002; Egas et al. 2004; Koelle et al. 2005).  
 Our goal in this study is to develop basic predictions for the evolution of 
influenza’s host range, though the methods of analysis are general and might be of 
interest also with regard to many other pathogens. Host range here refers to the 
specificity and diversity of pathogens in the community. Our analysis focuses on how a 
tradeoff in tissue specialization and host ecology may influence evolutionary outcomes in 
the long run. We do not consider the mechanistic details of evolutionary attainability 
here, since the genotype-to-phenotype maps relevant to influenza’s host range are still 
only poorly known (Baigent & McCauley 2003). Like Levins’s approach, ours ignores 
environmental variation, such as seasonality, and assumes that viral population dynamics 
are at equilibrium.  
 These simplifications allow us to obtain general results about the structure of host 
ranges in a heterogeneous host environment, when adaptation is restricted by a single 
evolutionary constraint. We find that specialists are favored for a broad range of weak 
and strong tradeoffs. It turns out that the ability of a second specialist to invade is very 
sensitive to interspecific transmission rates and host population sizes, but these 




The host range of many viruses is constrained by cell recognition (Baranowski et al. 
2001). Influenza viruses all bind to cell surface oligosaccharides with a terminal sialic 
acids. Sialic acids fall into one of two general types of conformations: the Neu5Acα(2,3)-
Gal linkage or the Neu5Acα(2,6)-Gal linkage. The intestinal and/or respiratory epithelia 
of waterfowl, horses, and dogs contain mainly cells with α2,3-linked sialic acids, 
whereas the upper respiratory epithelia of cats and humans are dominated by α2,6-linked 
sialic acid receptors (Baigent & McCauley 2003). Pigs, the alleged “mixing vessels” of 
influenza viruses (Webster et al. 1992), contain both types of receptors in their 
respiratory tracts (Scholtissek et al. 1998). Chickens also possess both types of receptors 
(Gambaryan et al. 2002). Experiments have shown that most viruses cannot replicate in 
host tissue of dissimilar receptor type, and viruses preferring one receptor type can 
usually sustain some replication in any host possessing that type, even if they are adapted 
to another species (Gambaryan et al. 2002; Ito & Kawaoka 2000; Ito et al. 1999; Kida et 
al. 1994; Lee et al. 2005). Thus, the chemistry of receptor binding creates a tradeoff 
between the ability to invade cells of one type or the other. No influenza A virus studied 
thus far appears able to bind both receptor conformations well simultaneously, though the 
tradeoffs may be more severe for some subtypes than for others (Harvey et al. 2004; 
Matrosovich et al. 2000; Matrosovich et al. 2001). 
 The distribution of α2,3- and α2,6-linked receptors in the host community 
presents an interesting evolutionary challenge: In a population of diverse potential hosts, 
under what circumstances will viruses evolve new receptor preferences? The emergence 
of avian influenza subtype H5N1 in humans has been ascribed to high interspecific 
mixing in backyard farms, high population densities in the expanding commercial poultry 
industry, and the presence of intermediate hosts, pigs or chickens, that serve as ecological 
and evolutionary bridges between waterfowl and humans (Bulaga et al. 2003; Liu et al. 
2003; Webster 2004; Webster & Hulse 2004). How easily could α2,6-adapted mutant 
viruses invade in these different environments, and would they be able to coexist in the 
long run with α2,3-adapted resident viruses? 
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 Here, we first ask how the host range of influenza changes with tradeoff strength 
in a neutral ecological model—except for differences in their receptors, host species are 
identical. We then adopt more realistic assumptions and explore how evolutionary 
dynamics are modulated by two major components of influenza’s ecology, interspecific 




We consider a community with three host populations. One population, with density Nr, 
represents the waterfowl reservoir and has only α2,3-receptors. Another population, with 
density Nt, represents the “target” population (e.g., cats or humans) and has only α2,6-
receptors. The third population, with density Nm, represents intermediate hosts such as 
pigs and chickens that possess both receptor types. We assume there are contacts between 
the reservoir and intermediate host (Nr and Nm) and between the intermediate and target 
hosts (Nm and Nt), but not between the reservoir and target host (figure 5.1a). 
 Epidemiological dynamics follow the susceptible-infected-recovered-susceptible 
(SIRS) model. The transition from recovered to susceptible indirectly captures two 
processes: the replenishment of susceptibles via birth and death processes and loss of 
immunity in recovered individuals due to antigenic evolution by the pathogen. Because 
our analysis considers only equilibrium numbers of susceptibles, infecteds, and 
recovereds, the SIRS model can represent the general features of a disease in a host 
population, such as a high level of immunity and low prevalence, or a high growth rate of 
the pathogen. 
 We initially assume that contact rates are frequency-dependent, with the 
interspecific transmission coefficient from host species j to species i, βij, equaling the 
average of the two corresponding intraspecific transmission coefficients scaled by a 
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Whether a contact results in transmission depends on the host’s receptor type and the 
virus’s receptor preference p. We define p as the probability of infecting via an α2,6-
receptor; a perfect α2,6-specialist thus has p = P(α2,6) = 1. The probability of infecting 
via an α2,3 receptor, P(α2,3), is related to P(α2,6) through a tradeoff with strength s 
(Egas et al. 2004), 
 
! 
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The tradeoff can be tuned to be weak (s < 1) or strong (s > 1). For later reference, we 
introduce three broad categories of viral phenotypes: α2,6 specialists, α2,3 specialists, 
and generalists. We further classify specialization as “low” or “high.” We consider an 
α2,6-specialist to have a low degree of specialization if 0.5 < P(α2,6) – P(α2,3) < 0.8 
and a high degree of specialization if P(α2,6) – P(α2,3) ≥ 0.8. The criteria for α2,3-
specialization are analogous. A virus is considered adapted to a receptor if it is 
specialized to that receptor. Generalist preferences comprise the remaining cases, 
|P(α2,6) – P(α2,3)| ≤ 0.5 (figure 5.1b). 
 Epidemiological dynamics in our model are represented by six ordinary 
differential equations. These equations follow from the rates dS/dt  and dI/dt at which the 
number of susceptible and infected hosts change in each of the three host species. Since 
we assume constant population sizes, the rates dR/dt at which the number of recovered 
hosts changes in each of the three host species follow from those equations. For each host 
i = r, m, t, the rate of susceptible replenishment is given by γi, the rate of infection by λi, 
and the rate of recovery by νi. Below we explicitly show the equations for each state of 











































and with the force of infection, λm, given by 
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Parameter c performs the same function as before, scaling the relative frequency of 
susceptibles of other species i perceived by an infected of species j (as c → 0, all 
transmission becomes intraspecific). In equation 2.1, parameter c describes how 
interspecific contact rates relate to intraspecific contact rates, which there scale only with 
the densities of susceptible and infected individuals. To obtain the force of infection with 
frequency dependent transmission, the same parameter is used again to scale the total 
population sizes of the other species. 
 Equations for the other hosts are analogous (supplementary material). As equation 
2.3d illustrates, in our model, infection of the intermediate host occurs via the receptor 
type to which the infecting virus is better adapted. 
 
Evolutionary dynamics 
To model the evolution of host range, we test the ability of a mutant virus with receptor 
preference p1 to invade a system of hosts infected with a resident virus of preference p2.  
To constrain the problem, we assume that, in each host class, the resident virus has 
reached the endemic equilibrium, and that the ability of the mutant to invade the resident 
is given by its instantaneous growth rate when rare in the environment determined by the 
resident. This growth rate, which is also known as the mutant’s invasion fitness in the 
resident’s environment (Metz et al. 1992), is given by the dominant eigenvalue of the 
Jacobian of the rare mutant’s epidemiological dynamics (supplementary material). 
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Entries (i,j) of this matrix describe the rate per mutant-infected host in class j at which the 
abundance of mutant-infected hosts in class i grows through transmission from those in 
class j when mutant-infected hosts are rare. The endemic equilibrium and the dominant 
eigenvalue were calculated numerically (since both are determined by polynomial 
equations with orders in excess of four). 
 By solving for the growth rate of every possible mutant phenotype against every 
possible resident phenotype, we can obtain pairwise invasibility plots (PIPs). PIPs show 
which phenotypes are uninvasible once reached and which phenotypes can be reached 
through the succession of small and advantageous mutational steps. The former 
phenotypes are called evolutionarily stable, the latter convergence stable. Our 
assumptions and approach are an application of the theory of adaptive dynamics 
(Dieckmann & Law 1996; Geritz et al. 1998; Metz et al. 1996). 
 
Results 
Effects of tradeoff strength in a neutral ecology  
We first examine how host range evolves when the host populations are identical in every 
respect but their receptors: hosts share the same population sizes and rates of birth, death, 
transmission, recovery, and susceptible replenishment, but their receptors vary (figure 
5.1a). For simplicity, we assume interspecific transmission rates equal intraspecific 
transmission rates (c = 1). 
 For very weak tradeoffs (in figure 5.2a, s = 0.05, s = 0.25, and s = 0.5), a 
complicated dynamic emerges. The pairwise invasibility plots show two strategies that 
are both evolutionarily and convergence stable, but only locally. Which strategies are 
realized depends on the phenotype of the initial resident and the mutational step size. For 
s = 0.5, starting from a perfect α2,3 specialist (resident p = 0), mutants that are, relative 
to the resident, slightly better adapted to the target host can invade up to p ≈ 0.23 (at this 
point, P(α2,3) ≈ 0.97). If mutations are always small, this resident, which shows a low 
degree of α2,3 specialization, will persist indefinitely. However, there is evidence that in 
at least some subtypes, single mutations can effect large changes in receptor-binding 
properties (Matrosovich et al. 2000; Tumpey et al. 2007). If mutations are large, mutants 
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with p higher than ≈ 0.7 can still invade. Invasions by mutants with successively higher p 
could push the resident strategy to p ≈ 0.97 (where P(α2,3) ≈ 0.23, corresponding to low 
α2,6 specialization). This other attractor is also locally evolutionarily and convergence 
stable. 
 As the tradeoff strengthens, the two local attractors disappear, and only the 
repellor previously separating them remains. The two perfect specialists (p = 0 and p = 1) 
become evolutionary end points. If mutational step sizes are small, only one perfect 
specialist will arise from a given starting condition. For example, if s  = 0.75, a resident 
starting at p = 0.5 can be progressively invaded by mutants with slightly smaller p until 
arriving at perfect α2,3 specialization. As before, which specialist appears depends on the 
phenotype of the initial resident. The plot also shows that if mutational step sizes are 
large, a mutant better adapted to α2,6-receptors (i.e., with P(α2,6) above ≈ 0.7) could 
invade against a perfect α2,3 resident and evolve increasing α2,6 specialization, and 
vice-versa. 
 Assuming that large mutations can occur and that multiple specialists are able to 
arise, will they coexist? Reflecting the plots across the main diagonal reveals areas of 
mutual invasibility, or coexistence: both the mutant and the resident have positive fitness 
in the background of the other type. Evaluating the selection gradient in the regions of 
coexistence shows whether this coexistence is transient or evolutionarily stable. When the 
tradeoff is very weak (s = 0.05, 0.25, and 0.5), we see the basins of attraction for the 
equilibria described previously (figure 5.2b). In addition, in the middle of the region of 
coexistence, we find a third attractor that is also locally evolutionarily stable. This kind of 
attractor is also known as a singular coalition (Geritz et al. 1998) [for a casual 
introduction, see Brännström and Festenberg (undated)]. At s = 0.5, this attractor occurs 
where one resident is highly α2,6-specialized and the other is highly α2,3 specialized. 
For stronger tradeoffs (s = 0.75 and above), this attractor is absent, and we find perfect 
specialists can coexist as evolutionary end points.  
 In summary, a neutral ecology almost always gives rise to pairs of specialists that 
are able to coexist in the long run; generalists only appear when the tradeoff is extremely 
weak (s = 0.05). These results appear robust for reasonable ecological parameters (figures 
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5.S1 and 2.S2). Our analysis up to this point reveals several further features of the 
evolution of host range in this system. First, PIPs are not anti-symmetric, that is, they are 
not invariant under reflection about the main diagonal and the subsequent exchange of 
signs. This demonstrates that selection for receptor preference is frequency-dependent 
[PIPs under frequency-independent selection are always anti-symmetric; Meszéna et al. 
(2001)]. Second, evolutionary branching, i.e., the endogenous generation of two different 
phenotypes from a single phenotype through frequency-dependent disruptive selection 
(Metz et al. 1992; Geritz et al. 1998), cannot occur in this system for a wide range of 
plausible ecological parameters (supplementary material). In other words, when a 
phenotype in our system is convergence stable, it will always experience stabilizing 
selection. Third, we find that once the tradeoff increases so that perfect specialists are 
evolutionary end points, further increases in tradeoff strength have virtually no effect on 
the invasion potential of strong α2,6-specialists. When perfect α2,3-specialists are 
endemic, approximately the same phenotypic threshold (P(α2,6) ⪞  0.7) governs 
invasions by α2,6-specialists.  
 
Effects of host ecology 
We explored how our results might be affected by ecological features that are relevant to 
influenza. First, we allow hosts to vary in their rates of transmission, recovery, and loss 
of infectiousness. Next, we introduce a modified version of the model that might better 
capture the dynamics of fecal-oral and confined aerosol transmission between and within 
the reservoir and intermediate host. We then examine the effects of two possible long-
term intervention strategies: changing the densities of intermediate and target hosts and 
the rates of mixing between different host species. 
 
Differences in host demography and epidemiology 
Natural host populations of influenza differ markedly in their quality, determined not 
only by their receptors but also demographic and epidemiologic rates. We consider two 
main features of host populations, the rate of susceptible replenishment γ and the intrinsic 
reproductive rate of the pathogen, R0, that each population allows. 
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 Parameter γ in equations 2.3a and 2.3c traditionally represents replenishment of 
the susceptible population through loss of immunity. It can also be used to regulate the 
densities of S*, I*, and R* at equilibrium, and thereby approximate the effects of birth, 
death, immigration, and emigration. We choose a relatively high value of γ (1/3 and 1/6 
months-1) for the reservoir and intermediate host, respectively, essentially claiming that a 
recovered individual will, on average, be replaced every three or six months by a 
susceptible. In the intermediate host, replacement mainly occurs through culling or sale. 
In waterfowl, it occurs mainly through loss of immunity and migration (Kida et al. 1980). 
We initially assume that γ is approximately fourfold smaller in the target host (i.e., 1/2 y-
1). This choice reflects the characteristic temporal scale of influenza’s antigenic evolution 
in humans, the longer life span of the target population, and a high rate of immigration 
and emigration events.  
 Better estimates are available of epidemiologic rates of transmission and recovery 
among influenza’s different hosts (supplementary material). A measure of a pathogen’s 
fitness in a population is the intrinsic reproductive number, R0, which equals the total 
number of secondary infections caused by the index case in a susceptible population. For 
















The intraspecific R0, or total number of secondary cases in the intermediate host 
population, is βmm/νm. Our parameters yield the maximum possible intraspecific R0 in the 
reservoir (R0 = 4 for a perfect α2,3 specialist), lowest in the target host (R0 = 1.5 for a 
perfect α2,6 specialist) and an intermediate R0 in the intermediate host (R0 = 1.75 for 
either perfect specialist). These choices of R0 and γ allow the highest prevalences (I*) to 
be reached in the reservoir, and the highest levels of immunity (R*) in the target host.   
  Changing the quality of the different host patches predictably breaks the 
symmetry in evolutionary outcomes. In general, if interspecific transmission rates equal 
intraspecific rates (c = 1) and the tradeoff is not especially weak (not s = 0.05 or 0.25) or 
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strong (s = 1.5), perfect α2,3 specialists will tend to dominate: they are the evolutionary 
end point from the majority of starting strategies, assuming small mutational step sizes 
(figures 5.S3-2.S5). Even if large mutations were possible, α2,6 specialists often cannot 
invade α2,3 residents, or invasion is allowed for only perfect or nearly perfect α2,6 
specialists. This restriction on α2,6-specialist invasion is influenced more by hosts’ 
differences in maximum possible growth rates (R0) than rates of susceptible 
replenishment, γ. If all host species have the same R0, poor α2,6 specialists can invade 
against a background of perfect α2,3 specialists even when susceptible replenishment in 
the target population is extremely slow (e.g., γt = 1/20 y-1) relative to the reservoir (γr = 
1/90 d-1) (figure 5.S3c,d). The two specialists will furthermore coexist evolutionarily. 
Increasing the maximum potential fitness of viruses in the reservoir eliminates this 
possibility (figure 5.S5).  
 
Density dependent transmission 
Influenza viruses appear to be transmitted predominantly by the fecal-oral route in wild 
waterfowl via contamination of shared water sources (Webster et al. 1992). Water is 
presumably the route by which they infect domesticated animals, including pigs and 
chickens. Pigs and chickens in confined feeding operations, whether commercial or 
family-owned, crowd at high densities and permit aerosol transmission (Alexander 2000; 
Brown 2000; Ly et al. 2007). We assume that rates of waterborne and aerosol 
transmission in confined areas scale more closely with the densities of infected 
individuals than the frequencies of infecteds in the population. This assumption 
corresponds to density-dependent transmission. Aerosol transmission by the potential 
target hosts is better represented by frequency dependence, as rates of contact between 
target and intermediate hosts are a saturating function [effectively, predation events; Ly 
et al. (2007) and Thiry et al. (2007)]. 
 Our modified model thus assumes density-dependent transmission within and 
between the reservoir and intermediate host and frequency-dependent transmission in the 
target host and between the target and intermediate host. For further analysis, we 
decouple the relative interspecific transmission parameter into c1 for transmission 
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between the reservoir and intermediate host and c2 for transmission between the 
intermediate and target hosts.  
 The force of infection perceived by the intermediate host, analogous to equation 
























* . (2.5) 
 
The shift from frequency dependent to density dependent transmission requires a change 
in the value and dimensions of βij for [i,j] ∈ {m,r}. We choose βij so that the initial 
growth rates in each host are identical to the frequency dependent case with Nr = Nm = 
100. We let the density dependent interspecific transmission rates scale with the 





























A complete analytic description of the model is in equations 2.S3-2.S5 (supplementary 
material). The consequences of this form of transmission will be explored in the context 
of possible intervention strategies.  
 
Intermediate and target host densities 
The densities of the intermediate and target hosts have nonlinear effects on the ability of 
α2,6 specialists to invade perfect α2,3 specialists. In general, increasing the density of 
the intermediate host population diminishes the ability of α2,6 specialists to invade by 
large mutations when perfect α2,3 specialists are endemic. In contrast, increasing the 
density of the target host population improves the ability of α2,6-adapted viruses to 
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invade. These patterns hold for both frequency dependent and density dependent models, 
and in the neutral and non-neutral ecologies (figures 5.S6-2.S9).  
 There are nonetheless some notable quantitative differences in the evolutionary 
outcomes allowed by different models. Unsurprisingly, frequency-dependent 
transmission attenuates the effects of increasing densities. In otherwise neutral ecologies, 
even when the intermediate host is twice as large as the target host population, invasion 
by α2,6-adapted viruses with a low degree of specialization is still possible (figure 
5.S6a); similarly, invasion by α2,6 specialists is still possible when the target host 
population is roughly a fifth as large as the other hosts (figure 5.S8). In an otherwise 
neutral ecology, density dependent transmission between the reservoir and intermediate 
host still permits α2,6-invasion when intermediate host density is quite large (figure 
5.S6b). Incorporating species-specific differences in R0 and susceptible replenishment 
greatly restricts the densities allowing α2,6-invasion (figures 5.S7 and 2.S9). For 
intermediate tradeoff strengths (e.g., s = 0.75 and s = 1), α2,6 specialists cannot invade 
and coexist if the target host density is lower than the densities of other species or if the 
intermediate host density exceeds that of the other species. Interestingly, the target and 
intermediate host densities that form the threshold for α2,6 specialist invasion do not 
vary substantially as tradeoff strength varies from s = 0.25 to s = 1 (figures 5.S7 and 
2.S9). At a higher tradeoff strength (s = 1.5), both thresholds decrease.  
 
Relative rates of interspecific transmission 
The evolution of pathogens’ host range is potentially affected not only by the qualities 
and sizes of different host patches but also by rates of contact between them. In 
particular, it is interesting to ask whether reducing the intermediate host’s relative rate of 
contact with the reservoir population, c1, has a greater effect on host range evolution than 
reducing rates of contact between the intermediate host and target population, c2.  
 The ability of α2,6 specialists to invade and coexist with α2,3 residents increases 
as interspecific contact rates decline. This result holds when interspecific transmission 
rates are considered separately (as c1 and c2) in the density dependent case in both neutral 
and non-neutral ecologies (figures 5.S11 and 2.S12). It is also true in the frequency 
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dependent case when interspecific contact rates c1 and c2 are varied together as c (figure 
5.S10). In neutral ecologies, the ability of α2,6 viruses to invade is slightly more 
sensitive to changes in interspecific contact between the target and intermediate hosts 
than between the reservoir and intermediate hosts (figures 5.S11a and 2.S12a). 
Nonetheless, a neutral ecology permits invasion of viruses with a low degree of α2,6 
specialization even when interspecific contact rates are twice intraspecific rates. Under 
more realistic ecologies, opportunities are much more restricted (figures 5.S11b and 
2.S12b).  For all but the weakest tradeoffs, an increase in interspecific transmission c1 
between the intermediate host and reservoir will quickly limit the invasion potential of 
α2,6-adapted viruses. Between the intermediate and target hosts, a slightly greater 
increase in relative transmission c2 is necessary to achieve the same effect. 
 Our findings show how the invasion potential of viral phenotypes is affected by 
tradeoff strength, target host density, and interspecific transmission. From this we can 
infer whether perfect α2,3- and α2,6-specialists can coexist in the absence of evolution. 
We find that, in general, coexistence is facilitated by low interspecific contact rates, a 
relatively low density of the intermediate host population, and a relatively high density of 
the target population (figure 5.3). In the frequency dependent model, such coexistence is 
stable even for high interspecific contact rates when the relative density of target hosts is 
high, and is stable even for low relative densities of target hosts when interspecific 
contact rates are low. Interestingly, these conditions appear relatively insensitive to 
tradeoff strength. Except at extremely weak tradeoffs (s ≈ 0.05), ecological coexistence 
denotes evolutionary coexistence; if perfect specialists do not coexist in the long run, 
extremely well-adapted specialists do. 
 
Discussion 
 We have shown how the evolution of host range, predicated on a single tradeoff, 
can be shaped by frequency-dependent selection, tradeoff strength, and host ecology. As 
expected, very weak tradeoffs favor generalist strategies. Unexpectedly, however, weak 
tradeoffs can promote the evolution and coexistence of viral phenotypes specialized on 
alternative receptor types, assuming large phenotypic mutations are possible. In that case, 
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both host ecology and tradeoff strength nonlinearly affect the ability of α2,6-adapted 
mutants to invade when α2,3-specialists are resident. The invasion of α2,6-adapted 
viruses is facilitated by low interspecific contact rates, small populations of intermediate 
hosts, and high densities of target hosts. 
 Tradeoff strength varies among influenza viruses. Viable intermediate phenotypes 
with dual receptor functionality have been reported for some subtypes and clades, but not 
for others. Matrosovich et al. (2001) identified a lineage of H9N2 from wild aquatic birds 
and poultry that retained relatively high binding affinity for both ovomucoid (α2,3-
receptors) and pig macroglobulin (α2,6-receptors). Experimental mutation of H5N1 also 
yielded seemingly infectious viruses with intermediate binding affinities (Harvey et al. 
2004). In contrast, strains of H1N1, H2N2, and H3N2 from humans and pigs showed 
only weak affinity for α2,3-sialosides, and a complete change in receptor preference 
resulting from only a few amino acid substitutions (Matrosovich et al. 2000; Tumpey et 
al. 2007). Our simple model predicts that subtypes with higher tradeoff strengths would 
more readily give rise to the long-term (evolutionary) coexistence of nearly perfect 
specialists. This pattern is in accordance with the observation that the subtypes that have 
circulated in humans (H1N1, H2N2, and H3N2) show evidence of affinity either to α2,3 
or α2,6 receptors, but not both simultaneously.  
 Our results lend strong support to the idea that certain ecologies facilitate 
expansions of host range. We find that, fortunately, the coexistence of specialists is much 
more difficult in influenza’s natural ecology than a neutral one. Assuming large 
mutations are possible, the invasion of α2,6-specialists is promoted by low interspecific 
contact rates, small intermediate host populations, and large target host populations. 
These changes increase the fraction of hosts that are susceptible to α2,6-mutants by 
limiting exposure to α2,3-viruses in the intermediate host. Low contact rates c1 between 
the reservoir and intermediate host enable α2,6 invasion by preserving a larger fraction of 
susceptibles in the intermediate host population. Low interspecific contact rates c2 reduce 
the fraction of target hosts’ contacts to intermediate hosts, which are apt to be resistant to 
infection from exposure to α2,3-adapted viruses. This reduction opposes a potential 
“dilution effect” of wasting contacts on incompetent (here, immune) hosts (Schmidt & 
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Ostfeld 2001). While the effect of increasing the population of the target host is 
unsurprising, a less intuitive result is that large intermediate host populations, by 
supporting increased transmission of α2,3-adapted viruses with the reservoir, thereby 
reduce the fraction of hosts potentially susceptible to α2,6-adapted viruses. Of course, 
large populations of intermediate hosts in nature could pose an increased risk for 
emergence if host density correlates with increased genetic diversity of the pathogen, and 
thus provides more mutant phenotypes (of potentially larger phenotypic range) on which 
selection can act. This result nonetheless underscores the major roles of immunity in the 
intermediate host population and rates of contact between target and intermediate hosts. 
 Notably, the effects of interspecific contact rates and host densities are nonlinear, 
indicating that small changes in host ecology can induce major shifts in viral phenotypes. 
In an environment where avian-adapted influenza is endemic, random mixing (c = 1) of 
hosts provides a natural inoculum for the community that prevents α2,6-adapted viruses 
from invading. Invasion of α2,6 specialists is more efficiently obtained by reducing 
contact rates between the intermediate and target hosts than intermediate hosts and the 
reservoir. Increasing the density of the target host so that it is larger than the other 
populations, or decreasing the intermediate host population to roughly one-tenth its 
former size, also allows invasion by α2,6-adapted specialists. 
 Our model makes general predictions about the long term evolution of pathogens 
facing tradeoffs in simple ecologies, but further investigations into the nonequilibrium 
dynamics of emergence would be useful. Influenza is seasonal in most animals, and 
transmission rates are likely also seasonal (Brown 2000; Halvorson et al. 1985; Munster 
et al. 2007; Viboud et al. 2006). If the amplitude of oscillations in the actual disease 
dynamics is sufficiently high, equilibria of viral evolution can be different from those 
predicted here (White et al. 2006). 
 Increasing genetic detail on receptor specificity in different viruses will also help 
address questions of evolutionary accessibility; the tradeoff between α2,3- and α2,6-
preference is only a first-order approximation of binding ability (Gambaryan et al. 2005), 
and receptor binding ability is one small, though critical, component of host range 
(Baigent & McCauley 2003). It might be feasible to model additional adaptations 
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indirectly as a change in the tradeoff strength, which we might expect to weaken over 
time (i.e., as increasingly better “molecular compromises” are found at the receptor-
binding site and also in other genes). It is also important to recognize the fundamentally 
probabilistic nature of adaptation. Though we considered our threshold for invasion to be 
positive growth of the mutant when rare, negative growth rates in nature stochastically 
generate chains of transmission that can be long enough to allow significant adaptation 
and ultimately positive growth (Andre & Day 2005; Antia et al. 2003). In other words, it 
may be possible for α2,6-adapted viruses to gain a foothold outside the areas of positive 
growth in the plots presented here.  
 This work shows that the evolution of host range may be as sensitive to ecological 
considerations as the physiological details of adaptation. The long term diversity of 
influenza viruses, for all realistic tradeoffs, is highly sensitive to host contact rates and 
population sizes. Naturally or artificially acquired immunity in the intermediate host and 
diluting contacts among competent hosts are key to reducing the long-term ability of 





Figure 5.1. Contact network and tradeoff in receptor preference. (a) Contact network, 
showing receptor conformations in three classes of host population: reservoir hosts 
(waterfowl; r), intermediate hosts (pigs and chickens; m), and target hosts (humans; t). 
Total host densities in each class are denoted by Ni with i = r, m, t. (b) Tradeoff for 
receptor preference. The strength of the tradeoff is given by s, with s < 1 characterizing a 
weak tradeoff and s > 1 a strong tradeoff. Moving away from the origin, the curves 
correspond to s = 1.5, 1, 0.75, 0.5, 0.25, and 0.05. Colors show degree of specialization 
on the nearby receptor: red (high specialization), orange (low specialization), and blue 
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Figure 5.2. Evolutionary outcomes in a neutral ecology. (a) Pairwise invasibility plots for 
different tradeoff strengths s for Nt =Nm =Nr and c = 1.0, βrr = βmm = βtt = 1/3 days-1, νr = 
νm = νt = 1/6 days-1, and γr = γm = γt  = 1/180 days-1. Black (white) areas indicate where 
the mutant has a positive (negative) growth rate in the endemic environment determined 
by the resident. Gray areas indicate regions in which the resident phenotype is not viable. 
(b) Trait evolution plots for the pairwise invasibility plots in (a). Gray areas indicate 
phenotype pairs that are mutually invasible. Black lines are isoclines and black circles 
correspond to evolutionary attractors if filled and repellors if open. Arrows show the 
direction at the quadrant level of selection pressure. For readability, they are shown here 

























Figure 5.3. Conditions that permit the coexistence of perfect specialists. The model 
assumes frequency dependent transmission, realistic host ecological parameters (table 
5.S1), and a neutral tradeoff (s = 1). The combinations that permit specialists’ coexistence 
are in gray. Coexistence is evolutionarily stable for higher tradeoffs (s = 0.75 and above) 
but not the weaker tradeoffs; however, even at weaker tradeoffs extremely well adapted 
viruses are able to coexist (see text, fig. 2.2). (a) Intermediate host’s relative population 
density Nm/Nr ( = Nm/Nt) and relative rate of contact with the reservoir, c1. (b) Target 
host’s relative population density, Nt/Nr ( = Nt/Nm), and relative rate of contact with the 














SIRS equations for reservoir and target hosts 
SIRS equations for the intermediate host are given in the main text (eqs. 2.3a-c). 








































































































































Jacobian of system with frequency-dependent transmission 
The Jacobian of this system shows the instantaneous rates of growth from an infected of 














































































































































































P1 refers to the phenotype of the mutant virus. 
 
Description of parameter values 
We chose parameters in keeping with general observations on the relative growth rates of 
different influenza subtypes in different hosts (Webster et al. 1992) (table 5.S1): 
• The rates of loss of immunity, γi, are qualitative estimates based on several 
observations. Rates are highest in waterfowl, since they appear to have little long-
term immunity to influenza. The intermediate hosts, as domesticated animals, also 
have relatively high turnover. Turnover rates in the target population are low due 
to longer host life spans and long-lasting immunity (whose loss is here a proxy for 
antigenic evolution). However, we assume they are offset by relatively high host 
mobility (migration). 
• The assumption of frequent, regular contact (suitable for transmission) between 
intermediate hosts and a target host population such as humans in both rural and 
more industrial settings is supported by serological surveys of pigs (Brown et al. 
1995; Olsen et al. 2000; Yu et al. 2007), asymptomatic pig farm workers 
(Campitelli et al. 1997; Halvorson et al. 1983; Karunakaran et al. 1983; Myers et 
al. 2006; Olsen et al. 2002; Sivanandan et al. 1991), and poultry workers 
(Koopmans et al. 2004).  
 
SIRS equations for model with density-dependent transmission 






































































































































































































































































Figure 5.S1. Evolutionary outcomes in a neutral ecology (intraspecific R0 = 1.5). 
Pairwise invasibility (a) and trait evolution (b) plots for hosts that are identical except for 
their receptor preferences. Parameters are identical to figure 5.2, except νr = νm = νt = 
1/4.5 days-1. Gray areas in (a) indicate regions where the resident is inviable, whereas in 
(b) they denote regions of coexistence. In the trait evolution plots, black lines are 
isoclines and black circles correspond to evolutionary attractors if filled and repellors if 
open. Arrows show the direction at the quadrant level of selection pressure. For clarity, 

























Figure 5.S2. Evolutionary outcomes in a neutral ecology (intraspecific R0 = 4). Pairwise 
invasibility (a) and trait evolution (b) plots for hosts that are identical except for their 
receptor preferences. Parameters are identical to figure 5.2, except νr = νm = νt = 1/12 
days-1. Gray areas in (b) denote regions of coexistence. In the trait evolution plots, black 
lines are isoclines and black circles correspond to evolutionary attractors if filled and 
repellors if open. Arrows show the direction at the quadrant level of selection pressure. 
For clarity, they are sometimes shown extending outside the plot, though phenotypes are 























Figure 5.S3. Evolutionary outcomes when hosts differ in rates of susceptible 
replenishment. Pairwise invasibility (a, c) and trait evolution (b, d) plots for host 
populations differing in their rates of susceptible replenishment, γ but not R0. In all plots, 
γr = 1/90 days-1 and γm = 1/180 days-1. The intraspecific R0 for all hosts is 2 (βrr = βmm = 
βtt = 1/3 days-1, νr = νm = νt = 1/6 days-1). Hosts have equal population sizes, interspecific 
transmission rates equal intraspecific rates (c = 1), and transmission rates are frequency 
dependent. In (a) and (b), γt = 1/730 days-1. In (c) and (d), γt = 1/7300 days-1. Gray areas 
in (a) indicate regions where the resident is inviable, whereas in (b) they denote regions 
of coexistence. In the trait evolution plots, black lines are evolutionary isoclines and 
black circles correspond to evolutionary attractors if filled and repellors if open. Arrows 
show the direction at the quadrant level of selection pressure. For clarity, they are 
































Figure 5.S4. Evolutionary outcomes when hosts differ in intraspecific R0. Pairwise 
invasibility (a) and trait evolution (b) plots for host populations differing in their R0 but 
not their rate of susceptible replenishment. Here, intraspecific R0 is 4 in the reservoir (βrr 
= 1/3 days-1, νr = 1/12 days-1), 1.75 in the intermediate host (βmm = 1/4 days-1, νm = 1/7 
days-1), and 1.5 in the target host (βtt = 1/4 days-1, νt = 1/6 days-1), as in table 5.S1. Hosts 
have identical population sizes and rates of susceptible replenishment (γr = γm = γt = 
1/180 days-1), interspecific transmission rates equal intraspecific rates (c = 1), and 
transmission rates are frequency dependent. Gray areas in (a) indicate regions where the 
resident is inviable, whereas in (b) they denote regions of coexistence. In the trait 
evolution plots, black lines are evolutionary isoclines and black circles correspond to 
evolutionary attractors if filled and repellors if open. Arrows show the direction at the 





























Figure 5.S5. Evolutionary outcomes when hosts differ both in R0 and rates of susceptible 
replenishment. Pairwise invasibility (a, c) and trait evolution (b, d) plots. Parameters are 
the same as those used for figure 5.S4, except where noted, and rates of susceptible 
replenishment are the same ones used for figure 5.S3 and listed in table 5.S1. For (c) and 
(d), intraspecific R0 in the reservoir (R0 = 2; νr = 1/6 days-1) is lower than in (a) and (b), 
though in both cases it is still higher than in the intermediate (R0 = 1.75) and target hosts 
(R0 = 1.5). Gray areas in (a) indicate regions where the resident is inviable, whereas in (b) 
they denote regions of coexistence. In the trait evolution plots, black lines are 
evolutionary isoclines and black circles correspond to evolutionary attractors if filled and 
































Figure 5.S6. Changing intermediate host density in a neutral ecology. Plots show (a) 
frequency dependent and (b) density dependent transmission. Ecological parameters are 
the same as those used in figure 5.2 (for all hosts, R0 = 2 and γ = 1/180 days-1). Pairwise 
invasibility and trait evolution plots corresponding to where Nm = Nt = Nr with frequency 
dependent transmission are shown in figure 5.2. Plus signs indicate areas of coexistence, 



















Figure 5.S7. Changing intermediate host density in a non-neutral ecology. Plots show (a) 
frequency dependent and (b) density dependent transmission. Ecological parameters are 
the same as those used in table 5.S1. Pairwise invasibility and trait evolution plots 
corresponding to where Nm = Nt = Nr with frequency dependent transmission are shown 
in figure 5.S5(a, b). Plus signs indicate areas of coexistence, which correspond to the gray 














region of inviability 
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Figure 5.S8. Changing target host density in a neutral ecology. Plots assume dependent 
transmission. Ecological parameters are the same as those used in figure 5.2 (for all hosts, 
R0 = 2 and γ = 1/180 days-1). Pairwise invasibility and trait evolution plots corresponding 
to where Nt = Nm = Nr with frequency dependent transmission are shown in figure 5.2. 








Figure 5.S9. Changing target host density in a non-neutral ecology. Plots assume 
frequency dependent transmission. Ecological parameters are the same as those used in 
table 5.S1. Pairwise invasibility and trait evolution plots corresponding to where Nt = Nm 
= Nr with frequency dependent transmission are shown in figure 5.S5(a,b). Plus signs 

















Figure 5.S10. Changing relative interspecific transmission rates identically (c = c1 = c2) 
when all transmission rates are frequency dependent. Coexistence plots are shown for (a) 
neutral and (b) non-neutral ecologies. Pairwise invasibility and trait evolution plots 
corresponding to the case where c = 1 are shown in figure 5.2 and figure 5.S5(a,b), 
respectively, assuming frequency dependent transmission. Plus signs indicate areas of 

















Figure 5.S11. Changing c1 only in (a) neutral and (b) non-neutral ecologies, assuming 
density-dependent transmission. Plus signs indicate areas of coexistence, which 



















Figure 5.S12. Changing c2 only in (a) neutral and (b) non-neutral ecologies, assuming 
density-dependent transmission. Plus signs indicate areas of coexistence, which 









Table 5.S1. Default parameter values used in non-neutral models 
 
 
Symbol Meaning Value References 
νr Rate of recovery in reservoir 1/(12 days) Hulse-Post et al. (2005) 
νm 
Rate of recovery in intermediate host 1/(7 days) Hinshaw et al. (1981), 
Brown (2000), Van der 
Groot et al. (2003) 
νt 
Rate of recovery in target population 1/(6 days) Leekha et al. (2007), 
Carrat et al. (2008) 
βrr Transmission coefficient in reservoir (1 contact)/(3 days)  
βmm 
Transmission coefficient in intermediate 
host 
(1 contact)/(4 days) Saenz et al. (2006) 
βtt 
Transmission coefficient in target 
population 
(1 contact)/(4 days) Saenz et al. (2006) 
γr 
Rate of susceptible replenishment in 
reservoir 
1/(90 days) Kida et al. (1980), Hulse-
Post et al. (2005) 
γm 
Rate of susceptible replenishment in 
intermediate host 
1/(180 days)  
γt 
Rate of susceptible replenishment in target 
population 
1/(730 days)  
c (c1, c2) 
Scaling coefficient for interspecific contact 
rates (between reservoir and intermediate 
host, between intermediate and target host) 
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The conflation of ecological and evolutionary time scales, characteristic of host 
interactions with viral and bacterial pathogens, guarantees that emerging infectious 
diseases will remain a threat to human populations for the indefinite future. These host-
pathogen interactions are also a wonderful frontier for science. Few other systems require 
integrating nonlinear dynamics across multiple scales and sifting through as many 
potential factors about host behavior, immune specificity, mechanisms of competition, 
and the pathogen’s immediate evolutionary potential. Improved surveillance should 
enhance this picture in the coming years and reveal recurring themes. This dissertation 
presented several explanations and possibilities for how the interplay of ecological and 
evolutionary dynamics can regulate the diversity of influenza in different host 
populations over different time scales. Though the analyses weight the contribution of 
each dynamic differently, they all suggest that accurate predictions about influenza—and 
potentially other pathogens—will not be possible without a phylodynamic perspective.  
 Chapter 2 measured the strength of positive selection on H3N2 viruses circulating 
in humans to evaluate evidence for a model of epochal evolution. Understanding the 
strength and targets of selection is important not only for developing better vaccines but 
also for predicting when a large fraction of the population might lose immunity, e.g., due 
to a mutation or reassortment. Such events are accompanied by increases in seasonal 
incidence. We found evidence for episodically strong and otherwise weak, continuous 
positive selection on the HA and positive selection (of unknown tempo) on NA, NP, and 
M2. That some positive selection appears to occur continuously in HA implies that the 
susceptible population is regularly replenished not only from births but also from 
individuals losing immunity. This dynamic makes eradication more difficult.  
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 Chapter 3 focused on identifying the ecological parameters associated with H3N2, 
H1N1, and influenza B in humans. The model implicitly included evolution in the loss of 
immunity. Improvements in the method of inference are required before conclusive 
results can be drawn. However, the fits reflect previously noted qualitative differences in 
the relative fitnesses of the different strains and suggest a possible role for cross-
immunity. The punctuated nature of antigenic evolution in H3N2 is also suggested by 
patterns of infection by age. 
 Chapter 4 showed that the diversity of immune responses has major consequences 
for strain diversity. Extremely low and extremely high diversity in responses at the 
population level and narrow responses at the individual level allow strains to coexist 
more easily. Future vaccination strategies may benefit from considering the diversity of 
responses in a population and immunogenicity of current and potential epitopes.   
Chapter 5 asked how host ecology could affect the long term evolution of 
influenza viruses’ host range, assuming a tradeoff in the ability to infect different hosts. 
Surprisingly, the strength of the tradeoff generally had very little effect on the outcome: 
What mattered far more were the densities of different host populations and the rates at 
which they contacted one another. However, this analysis also assumed that ecological 
dynamics always reached equilibrium between mutations. Analysis of nonequilibrium 
dynamics and incorporating specific molecular detail will be critical in developing 
policies to prevent spillovers and adaptation. 
 Our current understanding of influenza allows only for simple predictions, and 
this dissertation demonstrates the kinds of factors likely influencing dynamics in different 
host populations and time periods. Below, I outline specific areas where progress could 




Until recently, a lack of influenza surveillance in the tropics limited hypotheses about the 
role of space in influenza’s epidemiological and evolutionary dynamics. New 
observations of H3N2 show that strains in temperate latitudes frequently emigrate from 
East and Southeast Asia (Russell et al. 2008). Time series of viral isolations in E and SE 
Asia suggest that strains there go extinct locally (i.e., in individual cities) following 
epidemics, and the epidemics do not follow a clear seasonal pattern. The authors 
synthesized these observations in a verbal model, proposing that all meaningful evolution 
occurs in a network of populations in E and SE Asia, and that this network seeds annual 
epidemics in temperate latitudes. This has also been called the “source-sink” model 
(Rambaut et al. 2008). 
Another interesting observation from the study of Russell et al. (2008) is that the 
antigenic evolution of all strains globally appears relatively smooth and continuous in 
time. Antigenic evolution in Asia especially appears continuous, and its range does not 
appear to change dramatically from year to year. Critically, the antigenic distance 
accumulated in just one to two years is ostensibly enough to escape prior immunity in 
once-challenged ferrets (D. Smith, pers. comm.). How might influenza’s genetic and 
antigenic diversity be constrained in Asia over short time periods, e.g., within a single 
cluster? 
Though selective sweeps precipitated by cluster transitions may not be the major 
constraint (or only major constraint) on influenza’s evolution, that phenotypic jumps 
occur is still likely. The argument for the existence of antigenic clusters relied primarily 
on samples collected from temperate latitudes. If North America and Europe were indeed 
successfully seeded at annual intervals, sampling exclusively their isolates would make 
antigenic evolution appear more punctuated than if sampling included E and SE Asia. At 
the limit, one or two new clusters would then be reported every year, depending on the 
amount of sampling in each hemisphere. Instead, only eleven were identified over a 34-
year period, despite regular sampling. This difference implies that sampling bias alone 
cannot account for the existence of the clusters identified in Smith et al. (2004).  
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Cluster transitions may not be the main mechanism by which influenza’s diversity 
is restricted, however. Local extinctions followed by recolonization events—the latter 
brought about by spatial effects (e.g., differences in seasonal forcing and transmission 
rates between populations)—may be the essential factor in ensuring that roughly 
continuous antigenic evolution appears punctuated in any one location, allowing 
competitive exclusion of resident strains and antigenic drift at rates higher than permitted 
in the model of Koelle et al. (2006). It is hard to see how antigenic evolution could 
otherwise occur so rapidly in Asia from year to year without the rapid accumulation of 
antigenic or genetic diversity. In this model, abrupt phenotypic changes caused by cluster 
transitions can then augment strain displacement and would account for some of the 
interannual variation in antigenic diversity and attack rates; such transitions are not, 
however, dynamically essential to restrict diversity. It would be interesting to test 
whether a metapopulation model, where all populations are below the critical community 
size for endemic persistence, can produce realistic epidemiological and evolutionary 
dynamics with continuous antigenic evolution. It is possible that the relevant 
metapopulation for influenza’s evolution is not the network of populations in E and SE 
Asia but also includes North America, Europe, and Oceania, which can occasionally 
contribute successful strains to Asia (T. Bedford, pers. comm.). Ecological dynamics in 
space, and not the particular topology of influenza’s genotype-phenotype map, would 
then be the main shaper of influenza’s evolution.  
 
The complexity of immune-mediated interactions  
Chapter 5 highlighted some of the uncertainties in modeling competition between 
influenza strains. Uncertainty over the specificity, dynamics, and nature (cellular versus 
humoral) of the immune response drives the pursuit of diverse strategies in preparing 
seasonal and pandemic vaccines (Carrat & Flahault 2007; Doherty & Turner 2009; 
Mintern et al. 2009). Several recent studies have generated excitement in the popular 
press by identifying an epitope common to multiple subtypes (Sui et al. 2009; Throsby et 
al. 2008; Yoshida et al. 2009). The studies and others hint that conserved epitopes on HA 
or other proteins might form the basis of a “universal” vaccine, a prospect that has 
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attracted media attention (Hellemans 2008; Pollack 2009). Human antibodies to a 
conserved HA epitope were found in a preexisting antibody library, suggesting that at 
least a fraction of the human population may be able to produce such highly cross-
reactive antibodies to HA naturally (Sui et al. 2009). Another conserved epitope on M2 
has successfully induced antibodies in clinical trials (Hellemans 2008). 
 If protection against a conserved epitope could be generated through vaccination, 
it would allow the strain or subtype with the highest R0 to exclude other strains with that 
epitope; if vaccination rates were sufficiently high, extinction of all strains with the 
epitope could result. Unfortunately, influenza’s high mutation rate might allow escape 
mutations at the epitope or nearby, potentially through the addition of glycosylation sites. 
An attempt by one study to select escape mutants at a conserved HA epitope was 
unsuccessful but also very limited (Sui et al. 2009).  
 A deeper potential obstacle for the design of universal vaccines is that the basis of 
B cell selection is binding affinity, not neutralization ability. The best epitopes to attack 
to neutralize the virus are not always the most immunogenic (Ndifon et al. 2009). 
Influenza viruses might be under selection to evolve highly immunogenic but weakly 
neutralizing epitopes, which could potentially interfere with preexisting antibodies to 
highly efficient neutralizing epitopes (such as those around the receptor binding site), 
e.g., from a vaccine. There is evidence that seasonal immune escape by H3N2 might 
involve manipulating steric inhibition between antibodies (Ndifon et al. 2009). This 
dynamic increases the number of ways a virus can escape immunity. A clearer picture of 
the breadth and composition of existing B cell repertoires, epitopes’ relative 
immunogenicities, and opportunities for escape mutations should underlie future vaccine 
development. 
 
Long term strategies to manage influenza evolution 
Research on fundamental questions of influenza’s evolution could lead to a broad and 
flexible array of tools for managing the disease over the long term. The high mutation 
rate of RNA viruses has been ascribed to life history pressures, such as the need to escape 
adaptive immunity, and to a tradeoff with replication speed (Belshaw et al. 2008). The 
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major cost of a high mutation rate is poor replicative fidelity, which results, at the 
extreme (borrowing a term from quasispecies models), in error catastrophe: the fittest 
sequence cannot, on average, perfectly replicate itself, leading to an accumulation of 
deleterious mutations and a gradual loss of fitness.  
It seems reasonable to assume that influenza’s high mutation rate is partly driven 
by strong, negative frequency dependent selection by host immunity, especially 
antibodies to HA. (It would be interesting to test this hypothesis by comparing 
influenza’s substitution rates in different host species, whose populations will have 
different degrees of immune surveillance.) Strains with antigenically novel HA have a 
tremendous fitness advantage, but host immunity ensures that the advantage is only 
temporary. A strain with a temporarily superior fitness (due to mutations in HA) could 
also carry deleterious mutations on the HA and elsewhere. An interesting question is 
whether the intensity of negative frequency dependent selection could ever be so strong 
that over time, hitchhiking deleterious mutations cause a gradual decline in influenza’s 
fitness. A means by which influenza viruses in nature could escape this decline in non-
HA genes is through reassortment, the viral analogue of sex as a means to escape 
Muller’s ratchet. Are reassortment rates high enough to guarantee rescue from the 
accumulation of deleterious mutations? Could vaccinations be manipulated to intensify 
frequency dependent selection beyond the threshold where reassortment can correct the 
deleterious mutations? Answering these questions might require detailed knowledge of 
the virus’s genotype-phenotype map and the specificity of host immune responses. 
One of the treatments for chronic infections with hepatitis C viruses is ribavirin, 
an antiviral mutagen that is thought to destroy viral fitness by inducing error catastrophe 
(Cuevas et al. 2009). The structure of influenza’s genome suggests that it faces a delicate 
tradeoff between replication fidelity and replication speed. Its codon composition reflects 
evolved mutational robustness in conserved genes (Plotkin & Dushoff 2003), but it also 
contains overlapping reading frames, which increase sensitivity to random mutation in 
some parts of the genome. These relationships hint at potentially effective though 
theoretical interventions: forcing higher viral replication rates and focusing antiviral 
drugs and immune responses at proteins sharing overlapping reading frames (M1 and 
M2, NS1 and NS2) and other highly conserved areas. 
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The beautiful complexity of influenza’s dynamics creates an ironic obstacle to 
understanding through intense competition among scientists and policymakers. There is 
an unfortunate though narrowing gap between the strength of theory related to the 
pathogen and quality of management and surveillance. Quarantines, antiviral stockpiling, 
and movement restrictions imposed by health departments around the world in response 
to the emergence of a new variant of H1N1 in the spring of 2009 do not appear to be 
scientifically motivated. The heuristics of seasonal vaccine selection, despite being 
organized by an international government agency, also remain inscrutable. Quantities of 
antigenic and genetic information on par with what is publicly available remain largely 
restricted to handfuls of cooperating labs. It is the obligation of researchers not only to 
develop models with some predictive ability but also to try to share their results promptly 
with nonscientists and especially one another. Though influenza is a global problem, 
policy should also be driven by more than a few centralized agencies.  
Progress on pathogens such as influenza, HIV, parainfluenza, norovirus, 
Staphylococcus, Streptococcus, and many other bacteria and viruses will likely be 
synergistic. The dynamics of many are affected by interspecific transmission, seasonal 
forcing, serotype competition, heterogeneous immune responses, and rapid antigenic 
escape. Influenza’s blazing success as a pathogen should make it a challenging yet 





Belshaw, R., Gardner, A., Rambaut, A. & Pybus, O. G. 2008 Pacing a small cage: 
mutation and RNA viruses. Trends in Ecology & Evolution 23, 188-193. 
Carrat, F. & Flahault, A. 2007 Influenza vaccine: The challenge of antigenic drift. 
Vaccine 25, 6852-6862. 
Cuevas, J. M., Gonzalez-Candelas, F., Moya, A. & Sanjuan, R. 2009 Effect of Ribavirin 
on the Mutation Rate and Spectrum of Hepatitis C Virus In Vivo. Journal of 
Virology 83, 5760-5764. 
Doherty, P. C. & Turner, S. J. 2009 Thinking About Broadly Cross-Reactive Vaccines. 
Clinical Pharmacology & Therapeutics 85, 665-668. 
Hellemans, A. 2008 Can this man beat the flu with a single universal vaccine? In 
Scientific American. 
Koelle, K., Cobey, S., Grenfell, B. & Pascual, M. 2006 Epochal evolution shapes the 
phylodynamics of interpandemic influenza. Science 314, 1898-1903. 
Mintern, J. D., Bedoui, S., Davey, G. M., Moffat, J. M., Doherty, P. C. & Turner, S. J. 
2009 Transience of MHC Class I-restricted antigen presentation after influenza A 
virus infection. Proceedings of the National Academy of Sciences of the United 
States of America 106, 6724-6729. 
Ndifon, W., Wingreen, N. S. & Levin, S. A. 2009 Differential neutralization efficiency of 
hemagglutinin epitopes, antibody interference, and the design of influenza 
vaccines. Proceedings of the National Academy of Sciences of the United States of 
America 106, 8701-8706. 
Plotkin, J. B. & Dushoff, J. 2003 Codon bias and frequency-dependent selection on the 
hemagglutinin epitopes of influenza A virus. Proceedings of the National 
Academy of Sciences of the United States of America 100, 7152-7157. 
Pollack, A. 2009 A long search for a universal flu vaccine. In The New York Times. New 
York. 
Rambaut, A., Pybus, O. G., Nelson, M. I., Viboud, C., Taubenberger, J. K. & Holmes, E. 
C. 2008 The genomic and epidemiological dynamics of human influenza A virus. 
Nature 453, 615-620. 
Russell, C. A., Jones, T. C., Barr, I. G., Cox, N. J., Garten, R. J., Gregory, V., Gust, I. D., 
Hampson, A. W., Hay, A. J., Hurt, A. C., de Jong, J. C., Kelso, A., Klimov, A. I., 
Kageyama, T., Komadina, N., Lapedes, A. S., Lin, Y. P., Mosterin, A., Obuchi, 
M., Odagiri, T., Osterhaus, A. D. M. E., Rimmelzwaan, G. F., Shaw, M. W., 
Skepner, E., Stohr, K., Tashiro, M., Fouchier, R. A. M. & Smith, D. J. 2008 The 
global circulation of seasonal influenza A (H3N2) viruses. Science 320, 340-346. 
Smith, D. J., Lapedes, A. S., de Jong, J. C., Bestebroer, T. M., Rimmelzwaan, G. F., 
Osterhaus, A. D. M. E. & Fouchier, R. A. M. 2004 Mapping the antigenic and 
genetic evolution of influenza virus. Science 305, 371-376. 
Sui, J. H., Hwang, W. C., Perez, S., Wei, G., Aird, D., Chen, L. M., Santelli, E., Stec, B., 
Cadwell, G., Ali, M., Wan, H. Q., Murakami, A., Yammanuru, A., Han, T., Cox, 
N. J., Bankston, L. A., Donis, R. O., Liddington, R. C. & Marasco, W. A. 2009 
Structural and functional bases for broad-spectrum neutralization of avian and 
human influenza A viruses. Nature Structural & Molecular Biology 16, 265-273. 
 172 
Throsby, M., van den Brink, E., Jongeneelen, M., Poon, L. L. M., Alard, P., Cornelissen, 
L., Bakker, A., Cox, F., van Deventer, E., Guan, Y., Cinatl, J., ter Meulen, J., 
Lasters, I., Carsetti, R., Peiris, M., de Kruif, J. & Goudsmit, J. 2008 
Heterosubtypic neutralizing monoclonal antibodies cross-protective against H5N1 
and H1N1 recovered from human IgM+ memory B cells. PLoS One 3, e3942. 
Yoshida, T., Igarashi, M., Ozaki, H., Kishida, N., Tomabechi, D., Kida, H., Ito, K. & 
Takada, A. 2009 Cross-protective potential of a novel monoclonal antibody 
directed against antigenic site B of the hemagglutinin of influenza A viruses. 
PLoS Pathogens 5, e10000350. 
 
 
